Background  	Background  	 NN	O
A  	A  	 DT	O
near-universal  	near-universal  	 JJ	B-NP
feature  	feature  	 NN	I-NP
of  	of  	 IN	O
cell  	cell  	 NN	O
signaling  	signaling  	 VBG	O
via  	via  	 IN	O
seven  	seven  	 CD	O
transmembrane 	transmembrane 	 NN	B-NP
,  	,  	 ,	O
G  	G  	 NNP	B-NP
protein-coupled  	protein-coupled  	 JJ	I-NP
receptors  	receptors  	 NN	I-NP
is  	is  	 VBZ	O
attenuation  	attenuation  	 VBN	O
of  	of  	 IN	O
a  	a  	 DT	O
cellular  	cellular  	 JJ	B-NP
response  	response  	 NN	I-NP
upon  	upon  	 IN	O
prolonged  	prolonged  	 JJ	O
exposure  	exposure  	 NN	O
to  	to  	 TO	O
an  	an  	 DT	O
extracellular  	extracellular  	 JJ	B-NP
stimulus  	stimulus  	 NNS	I-NP
[  	[  	 -LRB-	O
1  	1  	 LS	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
desensitization  	desensitization  	 JJ	B-NP
process  	process  	 NN	I-NP
is  	is  	 VBZ	O
well-established  	well-established  	 JJ	O
for  	for  	 IN	O
GnRH-stimulated  	GnRH-stimulated  	 NNP	B-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 NN	I-NP
from  	from  	 IN	O
pituitary  	pituitary  	 JJ	B-NP
gonadotropes  	gonadotropes  	 NNS	I-NP
[  	[  	 -LRB-	O
2  	2  	 CD	O
3  	3  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
occurs  	occurs  	 VBZ	O
after  	after  	 IN	O
about  	about  	 IN	O
6  	6  	 CD	O
h  	h  	 NN	O
of  	of  	 IN	O
continued  	continued  	 JJ	O
exposure  	exposure  	 NN	O
to  	to  	 TO	O
GnRH  	GnRH  	 JJ	O
in  	in  	 IN	O
rats  	rats  	 NNS	O
[  	[  	 -LRB-	O
3  	3  	 LS	O
]  	]  	 -RRB-	O
;  	;  	 :	O
removal  	removal  	 NN	O
of  	of  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
permits  	permits  	 NNS	I-NP
recovery  	recovery  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
profound  	profound  	 JJ	O
suppression  	suppression  	 NN	O
of  	of  	 IN	O
LH  	LH  	 NNP	B-NP
secretion 	secretion 	 NN	I-NP
,  	,  	 ,	O
albeit  	albeit  	 IN	O
rather  	rather  	 RB	O
slowly  	slowly  	 RB	O
( 	( 	 -LRB-	O
2-4  	2-4  	 CD	O
days 	days 	 NNS	O
;  	;  	 :	O
4 	4 	 LS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
molecular  	molecular  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
involved  	involved  	 VBN	O
in  	in  	 IN	O
GnRH-induced  	GnRH-induced  	 JJ	B-NP
desensitization  	desensitization  	 NNS	I-NP
are  	are  	 VBP	O
poorly  	poorly  	 RB	O
understood 	understood 	 VBN	O
,  	,  	 ,	O
but  	but  	 CC	O
they  	they  	 PRP	O
do  	do  	 VBP	O
not  	not  	 RB	O
appear  	appear  	 VB	O
to  	to  	 TO	O
be  	be  	 VB	O
due  	due  	 JJ	O
to  	to  	 TO	O
alterations  	alterations  	 VB	O
in  	in  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
expression  	expression  	 NN	I-NP
[  	[  	 -LRB-	O
5  	5  	 CD	O
6  	6  	 CD	O
]  	]  	 -RRB-	O
or  	or  	 CC	O
to  	to  	 TO	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
LH  	LH  	 NNP	B-NP
concentrations  	concentrations  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
pituitary  	pituitary  	 JJ	B-NP
gland  	gland  	 NNS	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
8  	8  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Earlier 	Earlier 	 RBR	O
,  	,  	 ,	O
we  	we  	 PRP	O
presented  	presented  	 VBD	B-NP
evidence  	evidence  	 NN	I-NP
that  	that  	 IN	O
a  	a  	 DT	O
regulator  	regulator  	 NN	O
of  	of  	 IN	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
signaling 	signaling 	 NN	I-NP
,  	,  	 ,	O
RGS3 	RGS3 	 NNP	B-NP
,  	,  	 ,	O
might  	might  	 MD	O
participate  	participate  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
regulation  	regulation  	 NN	O
of  	of  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling  	signaling  	 NNS	O
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
RGS  	RGS  	 NNP	B-NP
action  	action  	 NN	I-NP
is  	is  	 VBZ	O
antagonism  	antagonism  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
Gα  	Gα  	 JJ	B-NP
protein  	protein  	 NN	I-NP
either  	either  	 CC	O
by  	by  	 IN	O
accelerating  	accelerating  	 VBG	O
its  	its  	 PRP$	O
hydrolysis  	hydrolysis  	 NN	B-NP
of  	of  	 IN	I-NP
GTP 	GTP 	 NNP	I-NP
,  	,  	 ,	O
thereby  	thereby  	 RB	O
prematurely  	prematurely  	 RB	O
terminating  	terminating  	 VBP	O
signaling  	signaling  	 VBG	O
due  	due  	 JJ	O
to  	to  	 TO	O
reassociation  	reassociation  	 VB	O
of  	of  	 IN	O
the  	the  	 DT	O
Gα  	Gα  	 NNP	B-NP
and  	and  	 CC	O
Gβγ  	Gβγ  	 NNP	B-NP
complexes  	complexes  	 NNS	I-NP
[  	[  	 -LRB-	O
10  	10  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
by  	by  	 IN	O
antagonizing  	antagonizing  	 JJ	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Gα  	Gα  	 JJ	B-NP
protein  	protein  	 NN	I-NP
with  	with  	 IN	O
its  	its  	 PRP$	O
effector  	effector  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
phospholipase  	phospholipase  	 JJ	B-NP
Cβ  	Cβ  	 NNP	I-NP
[  	[  	 -LRB-	O
11  	11  	 CD	O
12  	12  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
large  	large  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
RGS  	RGS  	 NNP	B-NP
genes  	genes  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
mammals  	mammals  	 VBG	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
120  	120  	 CD	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
core  	core  	 NN	I-NP
domain  	domain  	 NN	I-NP
[  	[  	 -LRB-	O
13  	13  	 CD	O
14  	14  	 CD	O
15  	15  	 CD	O
16  	16  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
RGS  	RGS  	 NNP	B-NP
proteins  	proteins  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
described  	described  	 VBN	O
that  	that  	 IN	O
interact  	interact  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
G  	G  	 NNP	O
i  	i  	 FW	O
α  	α  	 FW	O
and  	and  	 CC	O
G  	G  	 NNP	B-NP
qα  	qα  	 NN	I-NP
members  	members  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
G  	G  	 NNP	I-NP
protein  	protein  	 NN	I-NP
family  	family  	 NN	I-NP
[  	[  	 -LRB-	O
17  	17  	 CD	O
18  	18  	 CD	O
19  	19  	 CD	O
20  	20  	 CD	O
21  	21  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Previously 	Previously 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
showed  	showed  	 VBD	O
that  	that  	 IN	O
RSG3  	RSG3  	 NNP	B-NP
was  	was  	 VBD	O
expressed  	expressed  	 VBN	O
endogenously  	endogenously  	 VBN	O
in  	in  	 IN	O
rat  	rat  	 JJ	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
and 	and 	 CC	O
,  	,  	 ,	O
when  	when  	 WRB	O
experimentally  	experimentally  	 JJ	O
co-expressed  	co-expressed  	 NN	O
together  	together  	 RB	O
with  	with  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
heterologous  	heterologous  	 JJ	B-NP
cell  	cell  	 NN	I-NP
line  	line  	 NN	I-NP
( 	( 	 -LRB-	O
COS1 	COS1 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
it  	it  	 PRP	O
suppressed  	suppressed  	 VBD	B-NP
GnRH-stimulated  	GnRH-stimulated  	 JJ	I-NP
inositol  	inositol  	 JJ	I-NP
trisphosphate  	trisphosphate  	 JJ	I-NP
production  	production  	 NN	I-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Here 	Here 	 RB	O
,  	,  	 ,	O
those  	those  	 DT	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
extended  	extended  	 VBN	O
to  	to  	 TO	O
include  	include  	 VB	O
GnRH-stimulated  	GnRH-stimulated  	 JJ	B-NP
LH  	LH  	 NNS	I-NP
secretion  	secretion  	 VBP	O
using  	using  	 VBG	O
adenovirus-mediated  	adenovirus-mediated  	 JJ	B-NP
gene  	gene  	 NN	I-NP
transfer  	transfer  	 NN	I-NP
of  	of  	 IN	I-NP
RGS3  	RGS3  	 CD	I-NP
complementary  	complementary  	 JJ	I-NP
DNA  	DNA  	 NN	I-NP
into  	into  	 IN	O
normal  	normal  	 JJ	B-NP
rat  	rat  	 NN	I-NP
pituitary  	pituitary  	 NN	I-NP
gonadotropes 	gonadotropes 	 NN	I-NP
.  	.  	 .	O
RGS3  	RGS3  	 NNP	B-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
profoundly  	profoundly  	 RB	O
inhibit  	inhibit  	 VB	O
GnRH-stimulated  	GnRH-stimulated  	 JJ	B-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 NN	I-NP
and  	and  	 CC	O
3H-inositol  	3H-inositol  	 CD	O
phosphate  	phosphate  	 JJ	B-NP
accumulation 	accumulation 	 NN	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
calcium  	calcium  	 FW	B-NP
ionophore  	ionophore  	 FW	I-NP
stimulated  	stimulated  	 FW	I-NP
LH  	LH  	 FW	I-NP
secretion  	secretion  	 FW	I-NP
in  	in  	 FW	O
RGS3-expressing  	RGS3-expressing  	 FW	B-NP
gonadotropes 	gonadotropes 	 FW	I-NP
,  	,  	 ,	O
confirming  	confirming  	 VBG	O
a  	a  	 DT	O
specific  	specific  	 JJ	O
site  	site  	 NN	O
of  	of  	 IN	O
action  	action  	 NN	O
occurring  	occurring  	 VBG	O
at  	at  	 IN	O
phospholipase  	phospholipase  	 JJ	B-NP
Cβ  	Cβ  	 NNP	I-NP
or  	or  	 CC	O
earlier  	earlier  	 RBR	O
in  	in  	 IN	O
the  	the  	 DT	O
signal  	signal  	 NN	B-NP
transduction  	transduction  	 NN	I-NP
pathway 	pathway 	 NN	I-NP
.  	.  	 .	O
Results  	Results  	 NNS	O
The  	The  	 DT	O
initial  	initial  	 JJ	O
experiments  	experiments  	 NNS	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
to  	to  	 TO	O
confirm  	confirm  	 VB	O
our  	our  	 PRP$	O
earlier  	earlier  	 JJR	O
finding  	finding  	 NN	O
that  	that  	 IN	O
RGS3  	RGS3  	 NNP	B-NP
suppressed  	suppressed  	 VBD	I-NP
GnRH-stimulated  	GnRH-stimulated  	 NNP	I-NP
IP  	IP  	 NNP	I-NP
3  	3  	 CD	O
production  	production  	 NN	O
in  	in  	 IN	O
COS-1  	COS-1  	 CD	B-NP
cells  	cells  	 NNS	I-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
to  	to  	 TO	O
test  	test  	 VB	O
a  	a  	 DT	O
truncated  	truncated  	 JJ	O
form  	form  	 NN	O
of  	of  	 IN	O
RGS3 	RGS3 	 NNP	B-NP
,  	,  	 ,	O
RGS3T  	RGS3T  	 NNP	O
( 	( 	 -LRB-	O
RGS3  	RGS3  	 NNP	B-NP
314-519 	314-519 	 NNP	O
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
for  	for  	 IN	O
suppressive  	suppressive  	 JJ	B-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
assay  	assay  	 NNS	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
cDNAs  	cDNAs  	 JJ	O
representing  	representing  	 VBG	O
the  	the  	 DT	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
and  	and  	 CC	O
RGS3  	RGS3  	 NNP	B-NP
or  	or  	 CC	O
RGS3T  	RGS3T  	 NNP	O
were  	were  	 VBD	O
co-transfected  	co-transfected  	 JJ	B-NP
into  	into  	 IN	O
COS-1  	COS-1  	 CD	B-NP
cells  	cells  	 NNS	I-NP
for  	for  	 IN	I-NP
GnRH-A  	GnRH-A  	 JJ	I-NP
treatment  	treatment  	 NN	I-NP
72  	72  	 CD	O
h  	h  	 NNS	O
later 	later 	 RB	O
;  	;  	 :	O
intracellular  	intracellular  	 JJ	B-NP
IP  	IP  	 NNP	I-NP
3  	3  	 CD	O
concentrations  	concentrations  	 NNS	B-NP
were  	were  	 VBD	O
measured  	measured  	 VBN	O
at  	at  	 IN	O
0 	0 	 CD	O
,  	,  	 ,	O
10 	10 	 CD	O
,  	,  	 ,	O
20 	20 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
30  	30  	 CD	O
sec  	sec  	 NN	O
after  	after  	 IN	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	O
10  	10  	 CD	O
-7M  	-7M  	 CD	O
GnRH-A  	GnRH-A  	 NNS	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
As  	As  	 RB	O
expected 	expected 	 VBN	O
,  	,  	 ,	O
RGS3  	RGS3  	 NNP	B-NP
exerted  	exerted  	 VBD	O
a  	a  	 DT	O
profound  	profound  	 JJ	O
suppression  	suppression  	 NN	O
of  	of  	 IN	O
IP  	IP  	 NNP	B-NP
3  	3  	 CD	O
production  	production  	 NN	O
at  	at  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
time  	time  	 NN	B-NP
points  	points  	 NNS	I-NP
during  	during  	 IN	O
the  	the  	 DT	O
30  	30  	 CD	O
sec  	sec  	 NN	O
after  	after  	 IN	O
agonist  	agonist  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
RGS3T  	RGS3T  	 NNP	O
is  	is  	 VBZ	O
comprised  	comprised  	 VBN	O
primarily  	primarily  	 RB	O
by  	by  	 IN	O
the  	the  	 DT	O
consensus  	consensus  	 NN	B-NP
RGS  	RGS  	 NNP	I-NP
domain  	domain  	 NN	I-NP
and  	and  	 CC	O
was  	was  	 VBD	O
originally  	originally  	 RB	O
reported  	reported  	 VBN	O
to  	to  	 TO	O
decrease  	decrease  	 VB	O
the  	the  	 DT	O
growth  	growth  	 NN	B-NP
rate  	rate  	 NN	I-NP
of  	of  	 IN	O
yeast  	yeast  	 NN	O
and  	and  	 CC	O
to  	to  	 TO	O
inhibit  	inhibit  	 VB	O
IL-8  	IL-8  	 CD	B-NP
receptor  	receptor  	 NN	I-NP
mediated  	mediated  	 NN	I-NP
activation  	activation  	 NN	I-NP
of  	of  	 IN	I-NP
MAP  	MAP  	 NNP	I-NP
kinase  	kinase  	 NN	I-NP
by  	by  	 IN	O
a  	a  	 DT	O
factor  	factor  	 NN	B-NP
of  	of  	 IN	O
3-10  	3-10  	 NNP	O
fold  	fold  	 VBP	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
RGS3  	RGS3  	 CD	B-NP
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
was  	was  	 VBD	O
subsequently  	subsequently  	 RB	O
reported  	reported  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
a  	a  	 DT	O
normally  	normally  	 RB	O
expressed  	expressed  	 VBD	B-NP
variant  	variant  	 VBN	I-NP
of  	of  	 IN	I-NP
RGS3  	RGS3  	 NNP	I-NP
[  	[  	 -LRB-	O
37  	37  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
compared  	compared  	 VBD	O
it  	it  	 PRP	O
to  	to  	 TO	O
RGS3  	RGS3  	 CD	B-NP
for  	for  	 IN	I-NP
attenuation  	attenuation  	 NN	I-NP
of  	of  	 IN	I-NP
GnRH-stimulated  	GnRH-stimulated  	 NNP	I-NP
IP  	IP  	 NNP	I-NP
3  	3  	 CD	O
production  	production  	 NN	O
in  	in  	 IN	O
COS-1  	COS-1  	 CD	B-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
As  	As  	 RB	O
reported  	reported  	 VBN	O
by  	by  	 IN	O
others  	others  	 NNS	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
37  	37  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
we  	we  	 PRP	O
found  	found  	 VBD	O
that  	that  	 IN	O
RGS3T  	RGS3T  	 NNP	O
was  	was  	 VBD	O
more  	more  	 RBR	O
potent  	potent  	 JJ	O
than  	than  	 IN	O
RGS3  	RGS3  	 NNP	B-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Identification  	Identification  	 NN	B-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
C-terminal  	C-terminal  	 JJ	I-NP
205  	205  	 CD	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
variant  	variant  	 NN	I-NP
of  	of  	 IN	I-NP
RGS3  	RGS3  	 NNP	I-NP
that  	that  	 WDT	O
has  	has  	 VBZ	O
equal  	equal  	 JJ	O
or  	or  	 CC	O
greater  	greater  	 JJR	O
potency  	potency  	 NN	O
than  	than  	 IN	O
the  	the  	 DT	O
full-length  	full-length  	 JJ	O
519  	519  	 CD	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
RGS3  	RGS3  	 NN	I-NP
will  	will  	 MD	O
facilitate  	facilitate  	 VB	O
the  	the  	 DT	O
identification  	identification  	 NN	B-NP
of  	of  	 IN	I-NP
RGS3  	RGS3  	 CD	I-NP
functional  	functional  	 JJ	I-NP
protein  	protein  	 NN	I-NP
domains  	domains  	 NNS	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
important  	important  	 JJ	O
for  	for  	 IN	O
its  	its  	 PRP$	O
activity 	activity 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
family  	family  	 NN	O
of  	of  	 IN	O
RGS  	RGS  	 NNP	B-NP
proteins  	proteins  	 NNS	O
are  	are  	 VBP	O
established  	established  	 VBN	O
to  	to  	 TO	O
interact  	interact  	 VB	O
with  	with  	 IN	O
various  	various  	 JJ	O
Gα-protein  	Gα-protein  	 JJ	B-NP
subunits 	subunits 	 NN	I-NP
,  	,  	 ,	O
thereby  	thereby  	 RB	O
antagonizing  	antagonizing  	 VB	O
their  	their  	 PRP$	O
activities  	activities  	 NNS	O
[  	[  	 -LRB-	O
13  	13  	 CD	O
14  	14  	 CD	O
15  	15  	 CD	O
16  	16  	 CD	O
17  	17  	 CD	O
18  	18  	 CD	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Indeed 	Indeed 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
previously  	previously  	 RB	O
reported  	reported  	 VBN	O
that  	that  	 IN	O
RGS3  	RGS3  	 FW	B-NP
bound  	bound  	 FW	I-NP
Gqα  	Gqα  	 FW	I-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
subunit  	subunit  	 NN	I-NP
that  	that  	 IN	O
mediates  	mediates  	 JJ	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling  	signaling  	 NNS	O
[  	[  	 -LRB-	O
38  	38  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Here 	Here 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
have  	have  	 VBP	O
extended  	extended  	 VBN	O
those  	those  	 DT	O
binding  	binding  	 JJ	O
studies  	studies  	 NNS	O
to  	to  	 TO	O
include  	include  	 VB	O
other  	other  	 JJ	O
Gα  	Gα  	 JJ	B-NP
proteins  	proteins  	 NNS	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
An  	An  	 DT	O
RGS3-GST  	RGS3-GST  	 JJ	B-NP
fusion  	fusion  	 NN	I-NP
protein  	protein  	 NN	I-NP
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
an  	an  	 DT	O
35S-Met-Gα-protein 	35S-Met-Gα-protein 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
labeled  	labeled  	 JJ	O
Gα-protein  	Gα-protein  	 NN	B-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
using  	using  	 VBG	O
glutathione-coupled  	glutathione-coupled  	 JJ	B-NP
beads  	beads  	 NN	I-NP
to  	to  	 TO	O
"pull  	"pull  	 CD	O
down 	down 	 IN	O
"  	"  	 ``	O
the  	the  	 DT	O
RGS3-GST 	RGS3-GST 	 CD	B-NP
/  	/  	 CD	O
35S-Gα-protein  	35S-Gα-protein  	 CD	O
complex  	complex  	 NN	O
that  	that  	 WDT	O
was  	was  	 VBD	O
then  	then  	 RB	O
separated  	separated  	 VBN	O
and  	and  	 CC	O
quantified  	quantified  	 VBN	O
by  	by  	 IN	O
SDS 	SDS 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
PAGE  	PAGE  	 NNP	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
More  	More  	 JJR	O
Gqα  	Gqα  	 NNP	B-NP
was  	was  	 VBD	O
bound  	bound  	 VBN	O
by  	by  	 IN	O
RGS3  	RGS3  	 CD	B-NP
than  	than  	 IN	O
any  	any  	 DT	O
other  	other  	 JJ	O
protein 	protein 	 NN	B-NP
,  	,  	 ,	O
although  	although  	 IN	O
its  	its  	 PRP$	O
binding  	binding  	 NN	O
was  	was  	 VBD	O
not  	not  	 RB	O
significantly  	significantly  	 RB	O
different  	different  	 JJ	O
from  	from  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
Gzα  	Gzα  	 NNP	B-NP
and  	and  	 CC	O
Giα  	Giα  	 NNP	B-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
>  	>  	 CD	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Significant  	Significant  	 JJ	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
amounts  	amounts  	 NNS	O
of  	of  	 IN	O
Gi2α 	Gi2α 	 NNP	B-NP
,  	,  	 ,	O
Gi1α 	Gi1α 	 NNP	B-NP
,  	,  	 ,	O
Goα 	Goα 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
Gsα  	Gsα  	 NNP	B-NP
also  	also  	 RB	O
were  	were  	 VBD	O
bound  	bound  	 VBN	O
but  	but  	 CC	O
were  	were  	 VBD	O
not  	not  	 RB	O
as  	as  	 IN	O
high  	high  	 JJ	O
as  	as  	 IN	O
Gqα 	Gqα 	 NNP	B-NP
,  	,  	 ,	O
Gzα 	Gzα 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
Gi3α 	Gi3α 	 NNP	B-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
confirm  	confirm  	 VBP	O
our  	our  	 PRP$	O
previous  	previous  	 JJ	O
findings  	findings  	 NNS	O
that  	that  	 IN	O
RGS3  	RGS3  	 CD	B-NP
interacts  	interacts  	 NN	O
with  	with  	 IN	O
Gqα  	Gqα  	 NNP	B-NP
but  	but  	 CC	O
also  	also  	 RB	O
show  	show  	 VB	O
that  	that  	 IN	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
significant  	significant  	 JJ	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
all  	all  	 DT	O
other  	other  	 JJ	O
Gα-proteins  	Gα-proteins  	 JJ	B-NP
studied 	studied 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
findings  	findings  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
current 	current 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
an  	an  	 DT	O
earlier  	earlier  	 JJR	O
study  	study  	 NN	O
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
demonstrate  	demonstrate  	 VBP	O
clearly  	clearly  	 RB	O
that  	that  	 IN	O
RGS3  	RGS3  	 CD	B-NP
suppresses  	suppresses  	 CD	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling  	signaling  	 VBG	O
in  	in  	 IN	O
a  	a  	 DT	O
heterologous  	heterologous  	 JJ	B-NP
cell  	cell  	 NN	I-NP
system 	system 	 NN	I-NP
.  	.  	 .	O
Because  	Because  	 IN	O
of  	of  	 IN	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
signal  	signal  	 NN	B-NP
transduction  	transduction  	 NN	I-NP
pathway  	pathway  	 NN	I-NP
for  	for  	 IN	O
GnRH  	GnRH  	 JJ	O
in  	in  	 IN	O
gonadotropes  	gonadotropes  	 NN	B-NP
involves  	involves  	 VBZ	O
the  	the  	 DT	O
GnRH  	GnRH  	 JJ	B-NP
receptor 	receptor 	 NN	I-NP
,  	,  	 ,	O
Gqα 	Gqα 	 NNP	B-NP
,  	,  	 ,	O
phospholipase  	phospholipase  	 VBG	O
Cβ 	Cβ 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
cellular  	cellular  	 JJ	B-NP
IP  	IP  	 NNP	I-NP
3  	3  	 CD	O
release  	release  	 NN	O
[  	[  	 -LRB-	O
39  	39  	 CD	O
40  	40  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
we  	we  	 PRP	O
determined  	determined  	 VBD	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
RGS3  	RGS3  	 CD	B-NP
on  	on  	 IN	O
GnRH-stimulated  	GnRH-stimulated  	 NNP	B-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 VBZ	O
using  	using  	 VBG	O
adenoviral-mediated  	adenoviral-mediated  	 JJ	B-NP
gene  	gene  	 NN	I-NP
transfer  	transfer  	 NN	I-NP
in  	in  	 IN	O
rat  	rat  	 JJ	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
3 	3 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
these  	these  	 DT	O
experiments 	experiments 	 NNS	O
,  	,  	 ,	O
we  	we  	 PRP	O
performed  	performed  	 VBD	O
a  	a  	 DT	O
dose-response  	dose-response  	 JJ	B-NP
test  	test  	 NN	I-NP
that  	that  	 WDT	O
included  	included  	 VBD	O
three  	three  	 CD	O
experimental  	experimental  	 JJ	B-NP
groups 	groups 	 NNS	I-NP
:  	:  	 :	O
uninfected 	uninfected 	 CD	B-NP
,  	,  	 ,	O
adeno-β  	adeno-β  	 JJ	B-NP
galactosidase 	galactosidase 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
adeno-RGS3  	adeno-RGS3  	 CD	B-NP
infected 	infected 	 NNS	O
.  	.  	 .	O
Adeno-βgal  	Adeno-βgal  	 JJ	B-NP
infection  	infection  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
for  	for  	 IN	O
determination  	determination  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
fraction  	fraction  	 NN	I-NP
of  	of  	 IN	O
cells  	cells  	 NNS	O
infected  	infected  	 VBN	O
at  	at  	 IN	O
each  	each  	 DT	O
dose  	dose  	 NN	O
of  	of  	 IN	O
virus  	virus  	 NN	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
3 	3 	 CD	O
,  	,  	 ,	O
top  	top  	 JJ	O
panel 	panel 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
as  	as  	 IN	O
a  	a  	 DT	O
control  	control  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
adeno-RGS3  	adeno-RGS3  	 CD	B-NP
on  	on  	 IN	O
GnRH-stimulated  	GnRH-stimulated  	 NNP	B-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 NNS	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
3 	3 	 CD	O
,  	,  	 ,	O
middle  	middle  	 JJ	O
panel 	panel 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Cell  	Cell  	 NN	O
viability 	viability 	 NN	O
,  	,  	 ,	O
measured  	measured  	 VBN	O
as  	as  	 IN	O
trypan  	trypan  	 JJ	B-NP
blue  	blue  	 JJ	I-NP
exclusion 	exclusion 	 NN	I-NP
,  	,  	 ,	O
varied  	varied  	 VBN	O
from  	from  	 IN	O
98.5-100.0 	98.5-100.0 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
3 	3 	 CD	O
,  	,  	 ,	O
top  	top  	 JJ	O
panel 	panel 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
fraction  	fraction  	 NN	B-NP
of  	of  	 IN	O
cells  	cells  	 NNS	O
infected  	infected  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
adenovirus  	adenovirus  	 NN	B-NP
depended  	depended  	 VBD	O
on  	on  	 IN	O
viral  	viral  	 JJ	B-NP
dose  	dose  	 NN	I-NP
( 	( 	 -LRB-	O
0-5.0  	0-5.0  	 NNP	O
M.O.I. 	M.O.I. 	 NNP	B-NP
;  	;  	 :	O
1  	1  	 CD	O
M.O.I.  	M.O.I.  	 CD	B-NP
=  	=  	 SYM	O
1  	1  	 CD	O
viral  	viral  	 FW	B-NP
particle 	particle 	 FW	I-NP
/ 	/ 	 FW	I-NP
pituitary  	pituitary  	 FW	I-NP
cell 	cell 	 FW	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
ranged  	ranged  	 VBD	O
from  	from  	 IN	O
about  	about  	 IN	O
2 	2 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
no  	no  	 UH	O
adenovirus 	adenovirus 	 UH	B-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
99.5 	99.5 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
5.0  	5.0  	 CD	O
M.O.I. 	M.O.I. 	 CD	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Adeno-βgal  	Adeno-βgal  	 NNP	B-NP
had  	had  	 VBD	O
no  	no  	 DT	O
effect  	effect  	 NN	O
on  	on  	 IN	O
LH  	LH  	 NNP	B-NP
secretion  	secretion  	 NN	I-NP
at  	at  	 IN	O
any  	any  	 DT	O
dose  	dose  	 NN	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
uninfected  	uninfected  	 JJ	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
3 	3 	 CD	O
,  	,  	 ,	O
middle  	middle  	 JJ	O
panel 	panel 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
an  	an  	 DT	O
inverse  	inverse  	 JJ	O
dose-related  	dose-related  	 JJ	O
effect  	effect  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
between  	between  	 IN	O
adeno-RGS3  	adeno-RGS3  	 NNP	B-NP
and  	and  	 CC	O
GnRH-stimulated  	GnRH-stimulated  	 NNP	B-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 NNS	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
3 	3 	 CD	O
,  	,  	 ,	O
bottom  	bottom  	 JJ	O
panel 	panel 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
RGS3  	RGS3  	 CD	B-NP
0.2  	0.2  	 CD	O
M.O.I.  	M.O.I.  	 CD	B-NP
was  	was  	 VBD	O
the  	the  	 DT	O
lowest  	lowest  	 JJS	O
dose  	dose  	 NN	O
to  	to  	 TO	O
inhibit  	inhibit  	 VB	O
LH  	LH  	 JJ	B-NP
secretion  	secretion  	 NNS	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
2.0  	2.0  	 CD	O
and  	and  	 CC	O
5.0  	5.0  	 CD	O
M.O.I.  	M.O.I.  	 CD	B-NP
exerted  	exerted  	 NN	O
near  	near  	 IN	O
complete  	complete  	 JJ	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
LH  	LH  	 NNP	B-NP
secretion 	secretion 	 NN	I-NP
;  	;  	 :	O
i.e.  	i.e.  	 FW	O
LH  	LH  	 FW	B-NP
concentrations  	concentrations  	 NNS	I-NP
in  	in  	 IN	O
these  	these  	 DT	O
two  	two  	 CD	O
latter  	latter  	 JJ	O
GnRH-treated  	GnRH-treated  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
differ  	differ  	 VB	O
from  	from  	 IN	O
their  	their  	 PRP$	O
cohort  	cohort  	 JJ	B-NP
controls  	controls  	 NNS	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
>  	>  	 CD	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
profound  	profound  	 JJ	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
GnRH-stimulated  	GnRH-stimulated  	 NNP	B-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 VBD	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
Fig.  	Fig.  	 CD	O
3required  	3required  	 CD	O
verification  	verification  	 NN	O
that  	that  	 IN	O
RGS3  	RGS3  	 CD	B-NP
expression  	expression  	 NN	I-NP
was  	was  	 VBD	O
induced  	induced  	 VBN	O
by  	by  	 IN	O
adeno-RGS3  	adeno-RGS3  	 CD	B-NP
infection 	infection 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
address  	address  	 VB	O
this  	this  	 DT	O
issue 	issue 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
performed  	performed  	 VBD	B-NP
RGS3  	RGS3  	 CD	I-NP
immunoblots  	immunoblots  	 NNS	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
4 	4 	 CD	O
)  	)  	 -RRB-	O
which  	which  	 WDT	O
showed  	showed  	 VBD	O
an  	an  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
RGS3  	RGS3  	 CD	B-NP
protein  	protein  	 NN	I-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
adeno-RGS3  	adeno-RGS3  	 NNP	B-NP
( 	( 	 -LRB-	O
5.0  	5.0  	 CD	O
M.O.I. 	M.O.I. 	 CD	B-NP
)  	)  	 -RRB-	O
infected  	infected  	 JJ	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
low  	low  	 JJ	O
to  	to  	 TO	O
negligible  	negligible  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
protein  	protein  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
uninfected  	uninfected  	 NN	B-NP
and  	and  	 CC	O
adeno-βgal  	adeno-βgal  	 JJ	B-NP
infected  	infected  	 JJ	O
groups 	groups 	 NNS	O
.  	.  	 .	O
As  	As  	 RB	O
evidenced  	evidenced  	 VBN	O
earlier 	earlier 	 RBR	O
,  	,  	 ,	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
locus  	locus  	 NN	I-NP
of  	of  	 IN	I-NP
RGS  	RGS  	 NNP	I-NP
protein  	protein  	 NN	I-NP
action  	action  	 NN	I-NP
is  	is  	 VBZ	O
thought  	thought  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
the  	the  	 DT	O
G  	G  	 NNP	O
protein  	protein  	 FW	O
α  	α  	 FW	O
subunit 	subunit 	 FW	O
,  	,  	 ,	O
specifically  	specifically  	 RB	O
Gqα  	Gqα  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
case  	case  	 NN	O
of  	of  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
activation 	activation 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Fig.  	Fig.  	 CD	O
5are  	5are  	 CD	O
consistent  	consistent  	 JJ	O
with  	with  	 IN	O
this  	this  	 DT	O
conclusion 	conclusion 	 NN	O
:  	:  	 :	O
adeno-RGS3  	adeno-RGS3  	 CD	B-NP
infection  	infection  	 NN	I-NP
of  	of  	 IN	O
rat  	rat  	 FW	O
pituitary  	pituitary  	 FW	O
cells  	cells  	 FW	O
profoundly  	profoundly  	 FW	O
suppressed  	suppressed  	 FW	O
GnRH-stimulated  	GnRH-stimulated  	 FW	O
3H-inositol  	3H-inositol  	 FW	O
phosphate  	phosphate  	 FW	O
accumulation 	accumulation 	 FW	O
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
are  	are  	 VBP	O
compatible  	compatible  	 JJ	O
with  	with  	 IN	O
a  	a  	 DT	O
molecular  	molecular  	 JJ	B-NP
site  	site  	 NN	I-NP
of  	of  	 IN	O
action  	action  	 NN	O
for  	for  	 IN	O
RGS3  	RGS3  	 CD	B-NP
being  	being  	 VBG	O
at  	at  	 IN	O
phospholipase  	phospholipase  	 JJ	O
C  	C  	 NNP	O
or  	or  	 CC	O
earlier  	earlier  	 RBR	O
in  	in  	 IN	O
the  	the  	 DT	O
signal  	signal  	 NN	B-NP
transduction  	transduction  	 NN	I-NP
pathway 	pathway 	 NN	I-NP
.  	.  	 .	O
Another  	Another  	 DT	O
experiment  	experiment  	 NN	O
conducted  	conducted  	 VBN	O
to  	to  	 TO	O
test  	test  	 VB	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
and  	and  	 CC	O
molecular  	molecular  	 JJ	B-NP
locus  	locus  	 NN	I-NP
of  	of  	 IN	I-NP
RGS3  	RGS3  	 CD	I-NP
action  	action  	 NN	I-NP
in  	in  	 IN	O
inhibiting  	inhibiting  	 JJ	O
GnRH-stimulated  	GnRH-stimulated  	 JJ	B-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 NN	I-NP
was  	was  	 VBD	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
adeno-RGS3  	adeno-RGS3  	 CD	B-NP
infected  	infected  	 JJ	O
cells  	cells  	 NNS	O
with  	with  	 IN	O
an  	an  	 DT	O
agent  	agent  	 NN	B-NP
that  	that  	 WDT	O
increases  	increases  	 VBZ	O
intracellular  	intracellular  	 JJ	B-NP
calcium  	calcium  	 NN	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
6 	6 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Calcium  	Calcium  	 NNP	B-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
established  	established  	 JJ	O
stimulator  	stimulator  	 NN	B-NP
of  	of  	 IN	I-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
thought  	thought  	 VBN	O
to  	to  	 TO	O
act  	act  	 VB	O
at  	at  	 IN	O
sites  	sites  	 NNS	O
downstream  	downstream  	 VBN	O
of  	of  	 IN	O
phospholipase  	phospholipase  	 JJ	O
C  	C  	 NNP	O
[  	[  	 -LRB-	O
39  	39  	 CD	O
40  	40  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
adeno-RGS3  	adeno-RGS3  	 CD	B-NP
infected  	infected  	 JJ	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
calcium  	calcium  	 JJ	B-NP
ionophore  	ionophore  	 NNS	I-NP
( 	( 	 -LRB-	O
A23187 	A23187 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Adeno-RSG3  	Adeno-RSG3  	 NNP	B-NP
inhibited  	inhibited  	 VBD	I-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
GnRH-treated  	GnRH-treated  	 JJ	B-NP
control  	control  	 NN	I-NP
group  	group  	 NN	I-NP
as  	as  	 IN	O
expected  	expected  	 VBN	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
6 	6 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
calcium  	calcium  	 FW	B-NP
ionphore  	ionphore  	 FW	I-NP
stimulated  	stimulated  	 FW	I-NP
LH  	LH  	 FW	I-NP
secretion  	secretion  	 FW	I-NP
in  	in  	 FW	O
RGS3-expressing  	RGS3-expressing  	 FW	B-NP
gonadotropes  	gonadotropes  	 FW	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
6 	6 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
an  	an  	 DT	O
effect  	effect  	 NN	O
that  	that  	 WDT	O
would  	would  	 MD	O
be  	be  	 VB	O
expected  	expected  	 VBN	O
if  	if  	 IN	O
the  	the  	 DT	O
RGS3  	RGS3  	 CD	B-NP
inhibition  	inhibition  	 NNS	I-NP
was  	was  	 VBD	O
exerted  	exerted  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Gqα  	Gqα  	 JJ	B-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
two  	two  	 CD	O
final  	final  	 JJ	B-NP
control  	control  	 NN	I-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
investigated  	investigated  	 VBD	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
adeno-RGS3  	adeno-RGS3  	 CD	B-NP
on  	on  	 IN	O
LH  	LH  	 NNP	B-NP
concentrations  	concentrations  	 NNS	I-NP
in  	in  	 IN	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
on  	on  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
binding  	binding  	 NNS	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
7 	7 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
neither  	neither  	 DT	O
case  	case  	 NN	O
did  	did  	 VBD	O
RGS3  	RGS3  	 RB	O
affect  	affect  	 VB	O
these  	these  	 DT	O
parameters  	parameters  	 NN	O
of  	of  	 IN	O
gonadotrope  	gonadotrope  	 JJ	B-NP
function  	function  	 NN	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
>  	>  	 CD	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Discussion  	Discussion  	 NN	O
The  	The  	 DT	O
quantity  	quantity  	 NN	O
of  	of  	 IN	O
LH  	LH  	 NNP	B-NP
secreted  	secreted  	 NN	I-NP
by  	by  	 IN	O
the  	the  	 DT	O
anterior  	anterior  	 JJ	O
pituitary  	pituitary  	 JJ	B-NP
gland  	gland  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
outcome  	outcome  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
interaction  	interaction  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
hypothalamic  	hypothalamic  	 JJ	B-NP
GnRH  	GnRH  	 JJ	I-NP
secretion  	secretion  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
gonadotrope  	gonadotrope  	 JJ	B-NP
responsiveness  	responsiveness  	 NN	I-NP
to  	to  	 TO	O
GnRH  	GnRH  	 NNP	B-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Quantitatively 	Quantitatively 	 NNP	O
,  	,  	 ,	O
gonadotrope  	gonadotrope  	 JJ	B-NP
responsiveness  	responsiveness  	 NN	I-NP
is  	is  	 VBZ	O
more  	more  	 RBR	O
important  	important  	 JJ	O
than  	than  	 IN	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
secretion 	secretion 	 NN	I-NP
;  	;  	 :	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
during  	during  	 IN	O
the  	the  	 DT	O
estrogen-stimulated  	estrogen-stimulated  	 JJ	B-NP
preovulatory  	preovulatory  	 JJ	I-NP
surge  	surge  	 NN	I-NP
of  	of  	 IN	I-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
rat  	rat  	 NN	O
there  	there  	 EX	O
is  	is  	 VBZ	O
a  	a  	 DT	O
5-fold  	5-fold  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
secretion  	secretion  	 NN	I-NP
but  	but  	 CC	O
a  	a  	 DT	O
50-fold  	50-fold  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
LH  	LH  	 NNP	B-NP
secretion  	secretion  	 NNS	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
quantity  	quantity  	 NN	O
of  	of  	 IN	O
GnRH  	GnRH  	 NN	B-NP
that  	that  	 WDT	O
will  	will  	 MD	O
evoke  	evoke  	 VB	O
a  	a  	 DT	O
normal  	normal  	 JJ	B-NP
preovulatory  	preovulatory  	 JJ	I-NP
LH  	LH  	 NNP	I-NP
surge  	surge  	 NN	I-NP
during  	during  	 IN	O
the  	the  	 DT	O
period  	period  	 NN	O
preceding  	preceding  	 VBG	O
ovulation  	ovulation  	 NNS	B-NP
will  	will  	 MD	O
induce  	induce  	 VB	O
only  	only  	 RB	O
a  	a  	 DT	O
small  	small  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
LH  	LH  	 NNP	B-NP
secretion  	secretion  	 NN	I-NP
at  	at  	 IN	O
other  	other  	 JJ	O
stages  	stages  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
estrous  	estrous  	 JJ	B-NP
cycle  	cycle  	 NN	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Similarly 	Similarly 	 RB	O
,  	,  	 ,	O
termination  	termination  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
preovulatory  	preovulatory  	 JJ	B-NP
LH  	LH  	 NNP	I-NP
surge  	surge  	 NN	I-NP
appears  	appears  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
due  	due  	 JJ	O
to  	to  	 TO	O
desensitization  	desensitization  	 VB	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
gonadotrope  	gonadotrope  	 NN	I-NP
to  	to  	 TO	O
GnRH  	GnRH  	 JJ	B-NP
action 	action 	 NN	I-NP
;  	;  	 :	O
in  	in  	 IN	O
the  	the  	 DT	O
sheep 	sheep 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
LH  	LH  	 NNP	B-NP
secretion  	secretion  	 NN	I-NP
precedes  	precedes  	 VBZ	O
the  	the  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
secretion  	secretion  	 NNS	I-NP
[  	[  	 -LRB-	O
41  	41  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
whereas  	whereas  	 VBG	O
in  	in  	 IN	O
the  	the  	 DT	O
rat 	rat 	 NN	O
,  	,  	 ,	O
although  	although  	 IN	O
the  	the  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
GnRH  	GnRH  	 JJ	O
and  	and  	 CC	O
LH  	LH  	 NNP	B-NP
secretion  	secretion  	 NNS	I-NP
are  	are  	 VBP	O
co-incident  	co-incident  	 JJ	B-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
there  	there  	 EX	O
is  	is  	 VBZ	O
evidence  	evidence  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
gonadotrope  	gonadotrope  	 NN	B-NP
is  	is  	 VBZ	O
already  	already  	 RB	O
desensitized  	desensitized  	 VBN	O
to  	to  	 TO	O
GnRH  	GnRH  	 NNP	B-NP
[  	[  	 -LRB-	O
42  	42  	 CD	O
43  	43  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
mechanisms  	mechanisms  	 NNS	O
that  	that  	 WDT	O
alter  	alter  	 VBP	O
gonadotrope  	gonadotrope  	 JJ	B-NP
responsiveness  	responsiveness  	 NN	I-NP
to  	to  	 TO	O
GnRH  	GnRH  	 NNS	B-NP
are  	are  	 VBP	O
unknown  	unknown  	 JJ	O
but  	but  	 CC	O
they  	they  	 PRP	O
do  	do  	 VBP	O
not  	not  	 RB	O
appear  	appear  	 VB	O
to  	to  	 TO	O
be  	be  	 VB	O
due  	due  	 JJ	O
to  	to  	 TO	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
number  	number  	 NN	O
or  	or  	 CC	O
LH  	LH  	 NNP	B-NP
stores  	stores  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
pituitary  	pituitary  	 JJ	B-NP
gland  	gland  	 NNS	I-NP
[  	[  	 -LRB-	O
5  	5  	 CD	O
6  	6  	 CD	O
7  	7  	 CD	O
8  	8  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
fraction  	fraction  	 NN	B-NP
of  	of  	 IN	I-NP
LH  	LH  	 NNP	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
released  	released  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
maximal  	maximal  	 JJ	B-NP
dose  	dose  	 NN	I-NP
of  	of  	 IN	O
GnRH  	GnRH  	 JJ	O
does  	does  	 NNS	O
vary  	vary  	 VBP	O
positively  	positively  	 RB	O
with  	with  	 IN	O
gonadotrope  	gonadotrope  	 JJ	B-NP
responsiveness  	responsiveness  	 NNS	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
elucidation  	elucidation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mechanisms  	mechanisms  	 NNS	O
altering  	altering  	 VBG	O
the  	the  	 DT	O
fraction  	fraction  	 NN	B-NP
of  	of  	 IN	I-NP
releasable  	releasable  	 JJ	I-NP
LH  	LH  	 NNP	I-NP
is  	is  	 VBZ	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
illuminate  	illuminate  	 VB	O
mechanisms  	mechanisms  	 NNS	O
of  	of  	 IN	O
gonadotrope  	gonadotrope  	 JJ	B-NP
responsiveness  	responsiveness  	 NN	I-NP
to  	to  	 TO	O
GnRH  	GnRH  	 NNP	B-NP
[  	[  	 -LRB-	O
44  	44  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Two  	Two  	 CD	O
molecular  	molecular  	 JJ	B-NP
loci  	loci  	 NNS	I-NP
recently  	recently  	 RB	O
have  	have  	 VBP	O
been  	been  	 VBN	O
implicated  	implicated  	 VBN	O
as  	as  	 IN	O
potential  	potential  	 JJ	B-NP
modulators  	modulators  	 NN	I-NP
of  	of  	 IN	I-NP
GnRH  	GnRH  	 JJ	I-NP
receptor  	receptor  	 NN	I-NP
signaling 	signaling 	 NNS	O
:  	:  	 :	O
one  	one  	 PRP	O
is  	is  	 VBZ	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
itself  	itself  	 PRP	O
[  	[  	 -LRB-	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
other  	other  	 JJ	O
is  	is  	 VBZ	O
the  	the  	 DT	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
that  	that  	 IN	O
transduces  	transduces  	 VBG	O
the  	the  	 DT	O
signal  	signal  	 NN	O
generated  	generated  	 VBD	O
by  	by  	 IN	O
binding  	binding  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
to  	to  	 TO	O
its  	its  	 PRP$	O
agonist  	agonist  	 NNS	B-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
With  	With  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
former  	former  	 JJ	O
locus 	locus 	 NN	O
,  	,  	 ,	O
G  	G  	 NNP	B-NP
protein  	protein  	 FW	I-NP
coupled  	coupled  	 FW	I-NP
receptor  	receptor  	 FW	I-NP
kinases  	kinases  	 FW	I-NP
( 	( 	 -LRB-	O
GRKs 	GRKs 	 NNP	B-NP
)  	)  	 -RRB-	O
act  	act  	 NN	O
in  	in  	 IN	O
an  	an  	 DT	O
agonist-specific  	agonist-specific  	 JJ	B-NP
manner  	manner  	 NN	I-NP
to  	to  	 TO	O
phosphorylate  	phosphorylate  	 VB	O
intracellular  	intracellular  	 JJ	B-NP
regions  	regions  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
receptor  	receptor  	 NN	I-NP
thus  	thus  	 RB	O
permitting  	permitting  	 VBG	O
β  	β  	 JJ	O
arrestin  	arrestin  	 JJ	O
binding  	binding  	 NN	O
that  	that  	 IN	O
sterically  	sterically  	 JJ	O
inhibits  	inhibits  	 JJ	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
association  	association  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
[  	[  	 -LRB-	O
1  	1  	 CD	O
45  	45  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
have  	have  	 VBP	O
reported  	reported  	 VBN	O
previously  	previously  	 RB	O
that  	that  	 IN	O
experimental  	experimental  	 JJ	B-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	O
GRKs  	GRKs  	 JJ	O
in  	in  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor-expressing  	receptor-expressing  	 JJ	I-NP
heterologous  	heterologous  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
COS-1 	COS-1 	 NNP	B-NP
)  	)  	 -RRB-	O
suppressed  	suppressed  	 VBD	B-NP
GnRH-stimulated  	GnRH-stimulated  	 NNP	I-NP
IP  	IP  	 NNP	I-NP
3  	3  	 CD	O
production 	production 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
that  	that  	 DT	O
co-expression  	co-expression  	 JJ	B-NP
of  	of  	 IN	I-NP
GRK2  	GRK2  	 NNP	I-NP
and  	and  	 CC	O
β-arrestin  	β-arrestin  	 JJ	B-NP
2  	2  	 CD	O
suppressed  	suppressed  	 CD	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling  	signaling  	 VBG	O
more  	more  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
either  	either  	 DT	O
alone  	alone  	 RB	O
[  	[  	 -LRB-	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Stronger  	Stronger  	 JJR	B-NP
evidence  	evidence  	 NN	I-NP
that  	that  	 IN	O
the  	the  	 DT	O
GRK 	GRK 	 FW	B-NP
/ 	/ 	 FW	I-NP
β  	β  	 FW	I-NP
arrestin  	arrestin  	 FW	I-NP
paradigm  	paradigm  	 FW	I-NP
may  	may  	 MD	O
play  	play  	 VB	O
a  	a  	 DT	O
role  	role  	 NN	O
in  	in  	 IN	O
regulating  	regulating  	 VBG	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling  	signaling  	 NN	I-NP
is  	is  	 VBZ	O
our  	our  	 PRP$	O
recent  	recent  	 JJ	O
finding  	finding  	 NN	O
that  	that  	 IN	O
adenovirus-mediated  	adenovirus-mediated  	 JJ	B-NP
gene  	gene  	 NN	I-NP
transfer  	transfer  	 NN	I-NP
of  	of  	 IN	I-NP
GRK2  	GRK2  	 CD	I-NP
into  	into  	 IN	O
normal  	normal  	 JJ	B-NP
pituitary  	pituitary  	 FW	I-NP
gonadotropes  	gonadotropes  	 FW	I-NP
suppressed  	suppressed  	 FW	I-NP
GnRH-stimulated  	GnRH-stimulated  	 FW	I-NP
LH  	LH  	 FW	I-NP
secretion  	secretion  	 FW	I-NP
and  	and  	 CC	O
IP  	IP  	 NNP	B-NP
3  	3  	 CD	O
production  	production  	 NN	O
[  	[  	 -LRB-	O
31  	31  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
no  	no  	 DT	O
evidence  	evidence  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
presented  	presented  	 VBN	O
for  	for  	 IN	O
a  	a  	 DT	O
direct  	direct  	 JJ	O
interaction  	interaction  	 NN	O
between  	between  	 IN	O
β-arrestin  	β-arrestin  	 JJ	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
GnRH  	GnRH  	 JJ	B-NP
receptor 	receptor 	 NN	I-NP
.  	.  	 .	O
With  	With  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
locus  	locus  	 NN	O
for  	for  	 IN	O
modulation  	modulation  	 NN	B-NP
of  	of  	 IN	I-NP
GnRH  	GnRH  	 JJ	I-NP
receptor  	receptor  	 NN	I-NP
signaling 	signaling 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
reported  	reported  	 VBD	O
earlier  	earlier  	 RBR	O
that  	that  	 IN	O
experimental  	experimental  	 JJ	B-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	I-NP
RGS3  	RGS3  	 NNP	I-NP
but  	but  	 CC	O
not  	not  	 RB	O
RGS1 	RGS1 	 CD	B-NP
,  	,  	 ,	O
2 	2 	 CD	O
,  	,  	 ,	O
or  	or  	 CC	O
4  	4  	 CD	O
in  	in  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
expressing  	expressing  	 VBG	I-NP
COS-1  	COS-1  	 CD	I-NP
cells  	cells  	 NNS	I-NP
suppressed  	suppressed  	 VBD	O
GnRH-stimulated  	GnRH-stimulated  	 NNP	O
IP  	IP  	 NNP	O
3  	3  	 CD	O
production  	production  	 NN	O
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
current  	current  	 JJ	O
report 	report 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
present  	present  	 JJ	O
evidence  	evidence  	 NN	O
strengthening  	strengthening  	 VBG	O
the  	the  	 DT	O
hypothesis  	hypothesis  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
regulatory  	regulatory  	 JJ	B-NP
role  	role  	 NN	I-NP
for  	for  	 IN	I-NP
RGS3  	RGS3  	 CD	I-NP
in  	in  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling 	signaling 	 NNS	O
:  	:  	 :	O
adenovirus-mediated  	adenovirus-mediated  	 JJ	B-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	I-NP
RGS3  	RGS3  	 CD	I-NP
in  	in  	 IN	O
normal  	normal  	 JJ	B-NP
pituitary  	pituitary  	 FW	I-NP
gonadotropes  	gonadotropes  	 FW	I-NP
profoundly  	profoundly  	 FW	O
inhibited  	inhibited  	 FW	B-NP
GnRH-stimulated  	GnRH-stimulated  	 FW	I-NP
LH  	LH  	 FW	I-NP
secretion  	secretion  	 FW	I-NP
and  	and  	 CC	O
3H-inositol  	3H-inositol  	 CD	O
phosphate  	phosphate  	 JJ	B-NP
accumulation 	accumulation 	 NN	I-NP
.  	.  	 .	O
Arguing  	Arguing  	 VBG	O
for  	for  	 IN	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
effect  	effect  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
stimulation  	stimulation  	 NN	O
of  	of  	 IN	O
LH  	LH  	 NNP	B-NP
secretion  	secretion  	 NN	I-NP
by  	by  	 IN	O
a  	a  	 DT	O
calcium  	calcium  	 JJ	B-NP
ionophore  	ionophore  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
failure  	failure  	 NN	O
of  	of  	 IN	O
LH  	LH  	 NNP	B-NP
stores  	stores  	 NNS	I-NP
and  	and  	 CC	O
GnRH-receptor  	GnRH-receptor  	 JJ	B-NP
binding  	binding  	 NN	I-NP
to  	to  	 TO	O
be  	be  	 VB	O
affected  	affected  	 VBN	O
by  	by  	 IN	O
RGS3 	RGS3 	 CD	B-NP
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
our  	our  	 PRP$	O
finding  	finding  	 NN	O
that  	that  	 IN	O
GnRH-stimulated  	GnRH-stimulated  	 NNP	B-NP
IP  	IP  	 NNP	I-NP
3  	3  	 CD	O
production  	production  	 NN	O
was  	was  	 VBD	O
inhibited  	inhibited  	 RB	O
supports  	supports  	 VBZ	O
the  	the  	 DT	O
locus  	locus  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
RGS3  	RGS3  	 JJ	B-NP
effect  	effect  	 NN	I-NP
as  	as  	 IN	O
residing  	residing  	 NN	O
at  	at  	 IN	O
phospholipase  	phospholipase  	 JJ	O
C  	C  	 NNP	O
or  	or  	 CC	O
earlier  	earlier  	 RBR	O
in  	in  	 IN	O
the  	the  	 DT	O
transduction  	transduction  	 JJ	B-NP
pathway 	pathway 	 NN	I-NP
,  	,  	 ,	O
most  	most  	 RBS	O
likely  	likely  	 JJ	O
at  	at  	 IN	O
the  	the  	 DT	O
Gα  	Gα  	 JJ	B-NP
protein  	protein  	 NN	I-NP
because  	because  	 IN	O
of  	of  	 IN	O
our  	our  	 PRP$	O
studies  	studies  	 NNS	O
both  	both  	 CC	O
earlier  	earlier  	 RBR	O
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
here  	here  	 RB	O
showing  	showing  	 VBG	O
that  	that  	 IN	O
RGS3  	RGS3  	 FW	B-NP
binds  	binds  	 FW	I-NP
Gqα  	Gqα  	 FW	I-NP
in  	in  	 FW	O
vitro 	vitro 	 FW	B-NP
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
stronger  	stronger  	 JJR	O
inhibitory  	inhibitory  	 JJ	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	O
RGS3T  	RGS3T  	 CD	O
than  	than  	 IN	O
RGS  	RGS  	 NNP	B-NP
3  	3  	 CD	O
on  	on  	 IN	O
COS  	COS  	 NNP	B-NP
cell  	cell  	 NN	O
function  	function  	 NN	O
was  	was  	 VBD	O
presumed  	presumed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
true  	true  	 JJ	O
also  	also  	 RB	O
for  	for  	 IN	O
gonadotrope  	gonadotrope  	 JJ	B-NP
function  	function  	 NN	I-NP
and  	and  	 CC	O
therefore  	therefore  	 RB	O
was  	was  	 VBD	O
not  	not  	 RB	O
tested  	tested  	 VBN	O
here 	here 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
determination  	determination  	 NN	B-NP
of  	of  	 IN	I-NP
RGS  	RGS  	 NNP	I-NP
specificity  	specificity  	 NN	O
for  	for  	 IN	O
receptor-G  	receptor-G  	 JJ	B-NP
protein  	protein  	 NN	I-NP
pairs  	pairs  	 NNS	I-NP
are  	are  	 VBP	O
currently  	currently  	 RB	O
unknown 	unknown 	 JJ	O
;  	;  	 :	O
i.e. 	i.e. 	 FW	O
,  	,  	 ,	O
we  	we  	 PRP	O
and  	and  	 CC	O
others  	others  	 NNS	O
have  	have  	 VBP	O
found  	found  	 VBN	O
that  	that  	 IN	O
several  	several  	 JJ	O
RGSs  	RGSs  	 JJ	O
interact  	interact  	 NN	O
with  	with  	 IN	O
Gqα  	Gqα  	 NNP	B-NP
but  	but  	 CC	O
only  	only  	 RB	O
one 	one 	 CD	O
,  	,  	 ,	O
RGS3 	RGS3 	 NNP	B-NP
,  	,  	 ,	O
has  	has  	 VBZ	O
potent  	potent  	 JJ	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
on  	on  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling 	signaling 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
instance 	instance 	 NN	O
,  	,  	 ,	O
RGS4  	RGS4  	 NNP	B-NP
and  	and  	 CC	O
RGS-GAIP  	RGS-GAIP  	 NNP	B-NP
[  	[  	 -LRB-	O
11  	11  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
RGS3  	RGS3  	 NNP	B-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
RGS2  	RGS2  	 NNP	B-NP
[  	[  	 -LRB-	O
46  	46  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
RGS7  	RGS7  	 NNP	B-NP
( 	( 	 -LRB-	O
our  	our  	 PRP$	O
unpublished  	unpublished  	 JJ	O
findings 	findings 	 NNS	O
)  	)  	 -RRB-	O
all  	all  	 DT	O
bind  	bind  	 NN	B-NP
Gqα 	Gqα 	 NNP	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
established  	established  	 JJ	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
that  	that  	 IN	O
transduces  	transduces  	 JJ	B-NP
GnRH  	GnRH  	 JJ	I-NP
receptor  	receptor  	 NN	I-NP
signaling  	signaling  	 NNS	O
[  	[  	 -LRB-	O
38  	38  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Nevertheless 	Nevertheless 	 RB	O
,  	,  	 ,	O
RGS2  	RGS2  	 NNP	B-NP
and  	and  	 CC	O
4  	4  	 CD	O
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
RGS-GAIP  	RGS-GAIP  	 JJ	B-NP
and  	and  	 CC	O
RGS7  	RGS7  	 NNP	B-NP
( 	( 	 -LRB-	O
our  	our  	 PRP$	O
unpublished  	unpublished  	 JJ	O
data 	data 	 NNS	O
)  	)  	 -RRB-	O
are  	are  	 VBP	O
weak  	weak  	 JJ	O
or  	or  	 CC	O
null  	null  	 JJ	O
inhibitors  	inhibitors  	 NN	O
of  	of  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling 	signaling 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
recent  	recent  	 JJ	O
report  	report  	 NN	O
seems  	seems  	 VBZ	O
to  	to  	 TO	O
have  	have  	 VB	O
clarified  	clarified  	 VBN	O
this  	this  	 DT	O
issue 	issue 	 NN	O
:  	:  	 :	O
RGS4  	RGS4  	 NNP	B-NP
must  	must  	 MD	O
bind  	bind  	 VB	O
not  	not  	 RB	O
only  	only  	 RB	O
Gqα  	Gqα  	 NNP	B-NP
but  	but  	 CC	O
also  	also  	 RB	O
selected  	selected  	 VBN	B-NP
Gq-coupled  	Gq-coupled  	 JJ	I-NP
receptors  	receptors  	 NNS	I-NP
before  	before  	 IN	O
it  	it  	 PRP	O
can  	can  	 MD	O
inhibit  	inhibit  	 VB	O
receptor  	receptor  	 JJ	O
signaling  	signaling  	 NNS	O
[  	[  	 -LRB-	O
47  	47  	 CD	O
48  	48  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Based  	Based  	 VBN	O
on  	on  	 IN	O
this  	this  	 DT	O
finding 	finding 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
propose  	propose  	 VBP	O
that  	that  	 IN	O
RGS3 	RGS3 	 NNP	O
's  	's  	 POS	O
binding  	binding  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 RB	O
to  	to  	 TO	O
Gqα  	Gqα  	 NNP	B-NP
accounts  	accounts  	 NNS	I-NP
for  	for  	 IN	O
its  	its  	 PRP$	O
specific  	specific  	 JJ	O
inhibiting  	inhibiting  	 NN	O
of  	of  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
signaling 	signaling 	 NN	I-NP
.  	.  	 .	O
Conclusions  	Conclusions  	 NNS	O
The  	The  	 DT	O
results  	results  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
current  	current  	 JJ	O
investigation  	investigation  	 NN	B-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
those  	those  	 DT	O
presented  	presented  	 VBN	O
earlier  	earlier  	 RBR	O
[  	[  	 -LRB-	O
31  	31  	 CD	O
]  	]  	 -RRB-	O
nominate  	nominate  	 VB	O
two  	two  	 CD	O
molecular  	molecular  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
as  	as  	 IN	O
playing  	playing  	 VBG	O
roles  	roles  	 NNS	O
in  	in  	 IN	O
setting  	setting  	 VBG	O
the  	the  	 DT	O
responsiveness  	responsiveness  	 JJ	B-NP
level  	level  	 NN	I-NP
of  	of  	 IN	I-NP
GnRH  	GnRH  	 JJ	I-NP
receptor  	receptor  	 NN	I-NP
signaling 	signaling 	 NNS	O
;  	;  	 :	O
i.e. 	i.e. 	 FW	O
,  	,  	 ,	O
the  	the  	 DT	O
RGS3  	RGS3  	 JJ	B-NP
system  	system  	 NN	I-NP
acts  	acts  	 NNS	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
transducing  	transducing  	 NN	I-NP
step  	step  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
GRK 	GRK 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
β  	β  	 VBD	I-NP
arrestin  	arrestin  	 JJ	I-NP
system  	system  	 NN	I-NP
acts  	acts  	 NNS	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor 	receptor 	 NN	B-NP
.  	.  	 .	O
Future  	Future  	 JJ	O
studies  	studies  	 NNS	O
must  	must  	 MD	O
address  	address  	 VB	O
whether  	whether  	 IN	O
both 	both 	 DT	O
,  	,  	 ,	O
neither 	neither 	 RB	O
,  	,  	 ,	O
or  	or  	 CC	O
only  	only  	 RB	O
one  	one  	 CD	O
of  	of  	 IN	O
these  	these  	 DT	O
mechanisms  	mechanisms  	 NNS	O
are  	are  	 VBP	O
physiologically  	physiologically  	 JJ	B-NP
relevant 	relevant 	 JJ	I-NP
.  	.  	 .	O
Materials  	Materials  	 NNS	O
and  	and  	 CC	O
Methods  	Methods  	 NNP	O
cDNA  	cDNA  	 JJ	B-NP
transfection  	transfection  	 NN	I-NP
of  	of  	 IN	I-NP
COS-1  	COS-1  	 CD	I-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
measurement  	measurement  	 NN	O
of  	of  	 IN	O
IP  	IP  	 NNP	O
3production  	3production  	 NNP	O
cDNA  	cDNA  	 NNP	O
representing  	representing  	 VBG	O
the  	the  	 DT	O
rat  	rat  	 JJ	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
was  	was  	 VBD	O
cloned  	cloned  	 VBN	O
into  	into  	 IN	O
pcDNA3  	pcDNA3  	 NNP	B-NP
as  	as  	 RB	O
described  	described  	 VBN	O
and  	and  	 CC	O
validated  	validated  	 VBP	O
previously  	previously  	 RB	O
[  	[  	 -LRB-	O
22  	22  	 CD	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
cDNAs  	cDNAs  	 FW	B-NP
representing  	representing  	 FW	I-NP
RGS3  	RGS3  	 FW	I-NP
and  	and  	 CC	O
RGS3T  	RGS3T  	 NNP	O
( 	( 	 -LRB-	O
RGS3  	RGS3  	 FW	B-NP
amino  	amino  	 FW	I-NP
acids  	acids  	 FW	I-NP
314-519 	314-519 	 FW	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
cloned  	cloned  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
eukaryotic  	eukaryotic  	 JJ	B-NP
expression  	expression  	 NN	I-NP
vector 	vector 	 NN	I-NP
,  	,  	 ,	O
rcCMV 	rcCMV 	 NNP	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
described  	described  	 VBN	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
COS-1  	COS-1  	 NNP	B-NP
cells  	cells  	 NNS	I-NP
cultured  	cultured  	 VBP	O
as  	as  	 RB	O
detailed  	detailed  	 VBN	O
before  	before  	 IN	O
[  	[  	 -LRB-	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
were  	were  	 VBD	O
co-transfected  	co-transfected  	 JJ	B-NP
with  	with  	 IN	O
GnRH  	GnRH  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
cDNA  	cDNA  	 NN	I-NP
and  	and  	 CC	O
RGS3  	RGS3  	 NNP	B-NP
or  	or  	 CC	O
RGS3T  	RGS3T  	 CD	O
cDNA  	cDNA  	 JJ	O
using  	using  	 VBG	O
Lipofectamine  	Lipofectamine  	 NNP	B-NP
( 	( 	 -LRB-	O
Life  	Life  	 NNP	O
Technologies 	Technologies 	 NNPS	O
,  	,  	 ,	O
Gaithersburg 	Gaithersburg 	 NNP	O
,  	,  	 ,	O
MD 	MD 	 NNP	O
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
72  	72  	 CD	O
h  	h  	 NNS	O
later 	later 	 RB	O
,  	,  	 ,	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
10  	10  	 CD	O
-7M  	-7M  	 CD	O
GnRH-A  	GnRH-A  	 NN	O
for  	for  	 IN	O
0 	0 	 CD	O
,  	,  	 ,	O
10 	10 	 CD	O
,  	,  	 ,	O
20 	20 	 CD	O
,  	,  	 ,	O
or  	or  	 CC	O
30  	30  	 CD	O
sec  	sec  	 NN	O
before  	before  	 IN	O
being  	being  	 VBG	O
collected  	collected  	 VBN	O
for  	for  	 IN	O
IP  	IP  	 NNP	B-NP
3  	3  	 CD	O
measurements  	measurements  	 NNS	B-NP
[  	[  	 -LRB-	O
22  	22  	 CD	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
IP  	IP  	 NNP	O
3  	3  	 CD	O
measurements  	measurements  	 NNS	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
on  	on  	 IN	O
COS-1  	COS-1  	 CD	O
cell  	cell  	 NN	O
cytosolic  	cytosolic  	 NNS	O
preparations  	preparations  	 VBP	O
using  	using  	 VBG	O
a  	a  	 DT	O
radioreceptor  	radioreceptor  	 JJ	O
assay  	assay  	 NN	O
in  	in  	 IN	O
which  	which  	 WDT	O
IP  	IP  	 NNP	O
3  	3  	 CD	O
and  	and  	 CC	O
3H-IP  	3H-IP  	 CD	O
3  	3  	 CD	O
compete  	compete  	 NN	O
for  	for  	 IN	O
binding  	binding  	 VBG	O
to  	to  	 TO	O
IP  	IP  	 NNP	O
3  	3  	 CD	O
receptors  	receptors  	 NNS	O
prepared  	prepared  	 VBN	O
from  	from  	 IN	O
calf  	calf  	 FW	O
cerebellum  	cerebellum  	 FW	O
membranes  	membranes  	 FW	O
[  	[  	 -LRB-	O
22  	22  	 CD	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
RGS3  	RGS3  	 NNP	B-NP
binding  	binding  	 NN	I-NP
of  	of  	 IN	I-NP
Gα-proteins  	Gα-proteins  	 JJ	I-NP
in  	in  	 IN	O
vitro  	vitro  	 CD	B-NP
RGS3  	RGS3  	 CD	I-NP
protein  	protein  	 NN	I-NP
fused  	fused  	 NN	I-NP
to  	to  	 TO	O
glutathione-S-transferase  	glutathione-S-transferase  	 NNP	B-NP
( 	( 	 -LRB-	O
RSG3-GST  	RSG3-GST  	 NNP	B-NP
fusion  	fusion  	 NN	I-NP
protein 	protein 	 NN	I-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
produced  	produced  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
pGEX-5x-1  	pGEX-5x-1  	 JJ	B-NP
system  	system  	 NN	I-NP
of  	of  	 IN	I-NP
Pharmacia  	Pharmacia  	 NNP	I-NP
as  	as  	 RB	O
detailed  	detailed  	 VBN	O
previously  	previously  	 RB	O
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
35S-Met  	35S-Met  	 FW	O
labeled  	labeled  	 FW	B-NP
Gα-proteins  	Gα-proteins  	 NNP	I-NP
were  	were  	 VBD	O
prepared  	prepared  	 VBN	O
in  	in  	 IN	O
vitro  	vitro  	 NNS	B-NP
using  	using  	 VBG	O
a  	a  	 DT	O
transcription 	transcription 	 FW	B-NP
/ 	/ 	 FW	I-NP
translation  	translation  	 FW	I-NP
protocol  	protocol  	 FW	I-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
cDNAs  	cDNAs  	 JJ	O
for  	for  	 IN	O
Gqα  	Gqα  	 NNP	B-NP
[  	[  	 -LRB-	O
25  	25  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
Gzα  	Gzα  	 NNP	B-NP
[  	[  	 -LRB-	O
26  	26  	 CD	O
]  	]  	 -RRB-	O
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
M.  	M.  	 NNP	O
I.  	I.  	 NNP	O
Simon 	Simon 	 NNP	O
;  	;  	 :	O
for  	for  	 IN	O
Gsα  	Gsα  	 NNP	B-NP
( 	( 	 -LRB-	O
ref 	ref 	 NN	B-NP
.  	.  	 .	O
No.  	No.  	 NNP	O
63315 	63315 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
Gi2α  	Gi2α  	 NNP	B-NP
( 	( 	 -LRB-	O
ref 	ref 	 NN	B-NP
.  	.  	 .	O
No.  	No.  	 NNP	O
63311 	63311 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
American  	American  	 NNP	B-NP
Type  	Type  	 NNP	I-NP
Culture  	Culture  	 NNP	I-NP
Collection  	Collection  	 NNP	I-NP
( 	( 	 -LRB-	O
ATCC 	ATCC 	 NNP	B-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
for  	for  	 IN	O
Gαo  	Gαo  	 NNP	B-NP
[  	[  	 -LRB-	O
27  	27  	 CD	O
]  	]  	 -RRB-	O
was  	was  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
Eva  	Eva  	 NNP	O
G.  	G.  	 NNP	O
Neer 	Neer 	 NNP	O
;  	;  	 :	O
for  	for  	 IN	O
Gi1α 	Gi1α 	 NNP	B-NP
,  	,  	 ,	O
[  	[  	 -LRB-	O
28  	28  	 CD	O
]  	]  	 -RRB-	O
from  	from  	 IN	O
G.  	G.  	 NNP	B-NP
R.  	R.  	 NNP	I-NP
Post 	Post 	 NNP	I-NP
;  	;  	 :	O
and 	and 	 CC	O
,  	,  	 ,	O
for  	for  	 IN	O
Gi3α  	Gi3α  	 NNP	B-NP
[  	[  	 -LRB-	O
29  	29  	 CD	O
]  	]  	 -RRB-	O
from  	from  	 IN	O
M.  	M.  	 NNP	O
G.  	G.  	 NNP	O
Farquhar 	Farquhar 	 NNP	O
.  	.  	 .	O
Binding  	Binding  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
of  	of  	 IN	I-NP
recombinant  	recombinant  	 JJ	I-NP
RGS3-GST  	RGS3-GST  	 CD	I-NP
fusion  	fusion  	 NN	I-NP
protein  	protein  	 NN	I-NP
to  	to  	 TO	O
35S-Met-Gα-proteins  	35S-Met-Gα-proteins  	 NNP	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
as  	as  	 IN	O
detailed  	detailed  	 JJ	O
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Glutathione-coupled  	Glutathione-coupled  	 JJ	B-NP
beads  	beads  	 NN	I-NP
were  	were  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
select  	select  	 VB	O
35S-Gα  	35S-Gα  	 CD	O
proteins  	proteins  	 NNS	O
bound  	bound  	 VBN	O
to  	to  	 TO	O
RGS3-GST 	RGS3-GST 	 CD	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
were  	were  	 VBD	O
then  	then  	 RB	O
eluted  	eluted  	 VBN	O
for  	for  	 IN	O
separation  	separation  	 NN	O
by  	by  	 IN	O
SDS 	SDS 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
PAGE  	PAGE  	 NNP	I-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
amount  	amount  	 NN	O
and  	and  	 CC	O
molecular  	molecular  	 JJ	B-NP
size  	size  	 NN	I-NP
of  	of  	 IN	O
35S-Gα  	35S-Gα  	 CD	O
protein  	protein  	 NN	O
were  	were  	 VBD	O
determined  	determined  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
Phosphor  	Phosphor  	 JJ	B-NP
imaging  	imaging  	 NN	I-NP
device  	device  	 NN	I-NP
( 	( 	 -LRB-	O
Molecular  	Molecular  	 NNP	B-NP
Dynamics 	Dynamics 	 NNPS	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Preparation  	Preparation  	 NN	O
of  	of  	 IN	O
Adeno-RGS3  	Adeno-RGS3  	 NNP	O
Recombinant  	Recombinant  	 NNP	O
adenovirus  	adenovirus  	 VBZ	O
containing  	containing  	 VBG	O
RGS3  	RGS3  	 NNP	O
cDNA  	cDNA  	 NNP	O
was  	was  	 VBD	O
prepared  	prepared  	 VBN	O
using  	using  	 VBG	O
procedures  	procedures  	 NNS	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
in  	in  	 IN	O
detail  	detail  	 NN	O
by  	by  	 IN	O
Becker  	Becker  	 NNP	O
et  	et  	 FW	O
al.  	al.  	 FW	O
[  	[  	 -LRB-	O
30  	30  	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
by  	by  	 IN	O
us  	us  	 PRP	O
[  	[  	 -LRB-	O
31  	31  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Human  	Human  	 NNP	B-NP
RGS3  	RGS3  	 NNP	I-NP
cDNA  	cDNA  	 NNP	I-NP
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
was  	was  	 VBD	O
restricted  	restricted  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
pRC 	pRC 	 JJ	B-NP
/ 	/ 	 NNP	I-NP
CMV  	CMV  	 NNP	I-NP
vector  	vector  	 NN	I-NP
with  	with  	 IN	O
EcoRI 	EcoRI 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
then  	then  	 RB	O
subcloned  	subcloned  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
corresponding  	corresponding  	 JJ	O
site  	site  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
pACCMVpLpa  	pACCMVpLpa  	 JJ	B-NP
plasmid 	plasmid 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
proper  	proper  	 JJ	O
orientation  	orientation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
RGS3  	RGS3  	 NNP	B-NP
cDNA  	cDNA  	 NNP	I-NP
was  	was  	 VBD	O
confirmed  	confirmed  	 VBN	O
by  	by  	 IN	O
nucleotide  	nucleotide  	 JJ	B-NP
sequencing 	sequencing 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
procedure  	procedure  	 NN	O
for  	for  	 IN	O
preparation  	preparation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
adenovirus  	adenovirus  	 NN	I-NP
was  	was  	 VBD	O
co-transfection  	co-transfection  	 JJ	B-NP
of  	of  	 IN	O
a  	a  	 DT	O
human  	human  	 JJ	O
embryonic  	embryonic  	 JJ	B-NP
kidney  	kidney  	 NN	I-NP
cell  	cell  	 NN	I-NP
line  	line  	 NN	I-NP
( 	( 	 -LRB-	O
HEK  	HEK  	 NNP	O
293 	293 	 CD	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
the  	the  	 DT	O
pACCMVpLpa  	pACCMVpLpa  	 JJ	B-NP
plasmid  	plasmid  	 NN	I-NP
and  	and  	 CC	O
another  	another  	 DT	O
plasmid  	plasmid  	 NN	B-NP
( 	( 	 -LRB-	O
pJM17 	pJM17 	 NNP	B-NP
)  	)  	 -RRB-	O
containing  	containing  	 VBG	O
most  	most  	 JJS	O
of  	of  	 IN	O
the  	the  	 DT	O
viral  	viral  	 JJ	B-NP
genome  	genome  	 NNS	I-NP
[  	[  	 -LRB-	O
30  	30  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
relatively  	relatively  	 RB	O
rare  	rare  	 JJ	O
recombination  	recombination  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
plasmids  	plasmids  	 NN	B-NP
occurs  	occurs  	 VBZ	O
in  	in  	 IN	O
the  	the  	 DT	O
HEK  	HEK  	 NNP	B-NP
293  	293  	 CD	O
cells  	cells  	 NNS	O
that  	that  	 WDT	O
reconstitutes  	reconstitutes  	 VBZ	O
the  	the  	 DT	O
adenoviral  	adenoviral  	 JJ	B-NP
genome 	genome 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
recombination  	recombination  	 JJ	B-NP
event  	event  	 NN	I-NP
reconstituting  	reconstituting  	 VBD	I-NP
adeno-RGS3  	adeno-RGS3  	 NNP	I-NP
was  	was  	 VBD	O
confirmed  	confirmed  	 VBN	O
using  	using  	 VBG	O
PCR  	PCR  	 NNP	B-NP
analysis  	analysis  	 NN	I-NP
to  	to  	 TO	O
detect  	detect  	 VB	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
RGS3  	RGS3  	 NNP	B-NP
cDNA 	cDNA 	 NNP	I-NP
.  	.  	 .	O
Next 	Next 	 JJ	O
,  	,  	 ,	O
adeno-RGS3  	adeno-RGS3  	 NNP	B-NP
was  	was  	 VBD	O
isolated  	isolated  	 VBN	O
by  	by  	 IN	O
clonal  	clonal  	 JJ	B-NP
selection  	selection  	 NN	I-NP
in  	in  	 IN	O
HEK  	HEK  	 NNP	B-NP
293  	293  	 CD	O
cells  	cells  	 NNS	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
second  	second  	 JJ	O
PCR  	PCR  	 NN	B-NP
to  	to  	 TO	O
confirm  	confirm  	 VB	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
RGS3  	RGS3  	 NNP	B-NP
cDNA 	cDNA 	 NNP	I-NP
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
large-scale  	large-scale  	 JJ	O
amplification  	amplification  	 NN	B-NP
and  	and  	 CC	O
titering  	titering  	 NN	B-NP
of  	of  	 IN	I-NP
adeno-RGS3  	adeno-RGS3  	 NNP	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
HEK  	HEK  	 NNP	B-NP
293  	293  	 CD	O
cells 	cells 	 NNS	O
.  	.  	 .	O
This  	This  	 DT	O
virus  	virus  	 NN	O
preparation  	preparation  	 NN	O
was  	was  	 VBD	O
used  	used  	 VBN	O
for  	for  	 IN	O
infection  	infection  	 NN	O
of  	of  	 IN	O
rat  	rat  	 JJ	O
pituitary  	pituitary  	 JJ	O
cells  	cells  	 NNS	O
[  	[  	 -LRB-	O
31  	31  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Culture  	Culture  	 NN	O
and  	and  	 CC	O
infection  	infection  	 NN	B-NP
of  	of  	 IN	O
rat  	rat  	 FW	O
pituitary  	pituitary  	 FW	O
cells  	cells  	 FW	O
Anterior  	Anterior  	 FW	O
pituitary  	pituitary  	 FW	O
glands  	glands  	 NN	O
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
female  	female  	 JJ	O
Charles  	Charles  	 NNP	O
River  	River  	 NNP	O
CD  	CD  	 NNP	O
rats  	rats  	 NNS	O
that  	that  	 WDT	O
were  	were  	 VBD	O
maintained  	maintained  	 VBN	O
in  	in  	 IN	O
accordance  	accordance  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
NIH  	NIH  	 NNP	B-NP
Guide  	Guide  	 NNP	O
for  	for  	 IN	O
the  	the  	 DT	O
Care  	Care  	 NNP	O
and  	and  	 CC	O
Use  	Use  	 NN	O
of  	of  	 IN	O
Laboratory  	Laboratory  	 NNP	O
Animals  	Animals  	 NNPS	O
using  	using  	 VBG	O
an  	an  	 DT	O
experimental  	experimental  	 JJ	B-NP
protocol  	protocol  	 NN	I-NP
that  	that  	 WDT	O
had  	had  	 VBD	O
been  	been  	 VBN	O
approved  	approved  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Institutional  	Institutional  	 NNP	B-NP
Animal  	Animal  	 NNP	I-NP
Care  	Care  	 NNP	I-NP
and  	and  	 CC	O
Use  	Use  	 NNP	B-NP
Committee 	Committee 	 NNP	I-NP
.  	.  	 .	O
The  	The  	 DT	O
pituitaries  	pituitaries  	 NN	O
were  	were  	 VBD	O
dispersed  	dispersed  	 VBN	O
with  	with  	 IN	O
trypsin  	trypsin  	 VBG	O
as  	as  	 RB	O
described  	described  	 VBN	O
before  	before  	 IN	O
[  	[  	 -LRB-	O
32  	32  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
mono-dispersed  	mono-dispersed  	 JJ	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
plated  	plated  	 VBN	O
into  	into  	 IN	O
poly-L-lysine  	poly-L-lysine  	 JJ	B-NP
coated  	coated  	 JJ	O
60  	60  	 CD	O
mm  	mm  	 CD	O
plastic  	plastic  	 JJ	B-NP
Petri  	Petri  	 JJ	I-NP
dishes  	dishes  	 NNS	I-NP
in  	in  	 IN	O
DMEM 	DMEM 	 NNP	B-NP
/ 	/ 	 CD	O
10 	10 	 CD	O
%  	%  	 NN	O
gelding  	gelding  	 NN	B-NP
horse  	horse  	 NN	I-NP
serum  	serum  	 VBZ	I-NP
containing  	containing  	 VBG	O
10  	10  	 CD	O
-9M  	-9M  	 CD	O
estradiol  	estradiol  	 NN	O
to  	to  	 TO	O
optimize  	optimize  	 VB	O
the  	the  	 DT	O
GnRH-responsiveness  	GnRH-responsiveness  	 JJ	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
gonadotropes  	gonadotropes  	 NN	I-NP
[  	[  	 -LRB-	O
33  	33  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
incubated  	incubated  	 JJ	O
overnight  	overnight  	 JJ	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
in  	in  	 IN	O
8 	8 	 CD	O
%  	%  	 NN	O
CO  	CO  	 NNP	O
2  	2  	 CD	O
-92 	-92 	 CD	O
%  	%  	 NN	O
air 	air 	 NN	O
.  	.  	 .	O
Pituitary  	Pituitary  	 JJ	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
infected  	infected  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
volume  	volume  	 NN	O
of  	of  	 IN	O
adeno-RGS3  	adeno-RGS3  	 NNP	O
or  	or  	 CC	O
adeno-β  	adeno-β  	 JJ	O
galactosidase  	galactosidase  	 JJ	O
necessary  	necessary  	 JJ	O
to  	to  	 TO	O
achieve  	achieve  	 VB	O
the  	the  	 DT	O
chosen  	chosen  	 JJ	O
multiplicity  	multiplicity  	 NN	O
of  	of  	 IN	O
infection  	infection  	 NN	O
( 	( 	 -LRB-	O
M.O.I. 	M.O.I. 	 NNP	O
)  	)  	 -RRB-	O
diluted  	diluted  	 VBN	O
to  	to  	 TO	O
0.3  	0.3  	 CD	O
ml 	ml 	 NNS	O
;  	;  	 :	O
this  	this  	 DT	O
was  	was  	 VBD	O
further  	further  	 RB	O
diluted  	diluted  	 VBN	O
with  	with  	 IN	O
1.2  	1.2  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
TS  	TS  	 NNP	O
buffer  	buffer  	 NN	O
( 	( 	 -LRB-	O
8.0  	8.0  	 FW	O
gm 	gm 	 FW	O
/ 	/ 	 FW	O
L  	L  	 NNP	O
NaCI 	NaCI 	 NNP	O
,  	,  	 ,	O
380  	380  	 CD	O
mg 	mg 	 CD	O
/ 	/ 	 CD	O
L  	L  	 NNP	O
KCl 	KCl 	 NNP	O
,  	,  	 ,	O
100  	100  	 CD	O
mg 	mg 	 CD	O
/ 	/ 	 CD	O
L  	L  	 NNP	O
Na  	Na  	 NNP	O
2  	2  	 CD	O
HPO  	HPO  	 CD	O
4  	4  	 CD	O
,  	,  	 ,	O
3.0  	3.0  	 FW	O
gm 	gm 	 FW	O
/ 	/ 	 FW	O
L  	L  	 NNP	O
Tris  	Tris  	 NNP	O
HCI 	HCI 	 NNP	O
,  	,  	 ,	O
200  	200  	 CD	O
mg 	mg 	 CD	O
/ 	/ 	 CD	O
L  	L  	 NNP	O
CaCl  	CaCl  	 NNP	O
2  	2  	 CD	O
·  	·  	 CD	O
2H  	2H  	 CD	O
2  	2  	 CD	O
O 	O 	 NNP	O
,  	,  	 ,	O
100  	100  	 CD	O
mg 	mg 	 CD	O
/ 	/ 	 CD	O
L  	L  	 NNP	O
MgCl  	MgCl  	 NNP	O
2  	2  	 CD	O
·  	·  	 CD	O
6H  	6H  	 CD	O
2  	2  	 CD	O
O 	O 	 NNS	O
;  	;  	 :	O
pH  	pH  	 JJ	O
7.4 	7.4 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
pituitary  	pituitary  	 JJ	O
cell  	cell  	 NN	O
culture  	culture  	 NN	O
medium  	medium  	 NN	O
was  	was  	 VBD	O
aspirated  	aspirated  	 JJ	O
and  	and  	 CC	O
replaced  	replaced  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
virus  	virus  	 NN	O
solution 	solution 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
in  	in  	 IN	O
a  	a  	 DT	O
CO  	CO  	 NNP	O
2  	2  	 CD	O
incubator  	incubator  	 NN	O
for  	for  	 IN	O
approximately  	approximately  	 RB	O
72  	72  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
Next 	Next 	 JJ	O
,  	,  	 ,	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
by  	by  	 IN	O
trypsinization  	trypsinization  	 NN	B-NP
and  	and  	 CC	O
counted  	counted  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
hemocytometer 	hemocytometer 	 NN	B-NP
;  	;  	 :	O
then 	then 	 RB	O
,  	,  	 ,	O
they  	they  	 PRP	O
were  	were  	 VBD	O
checked  	checked  	 VBN	O
for  	for  	 IN	O
viability  	viability  	 NN	O
using  	using  	 VBG	O
trypan  	trypan  	 JJ	B-NP
blue  	blue  	 JJ	I-NP
[  	[  	 -LRB-	O
31  	31  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
replated  	replated  	 VBN	O
for  	for  	 IN	O
2  	2  	 CD	O
h  	h  	 NN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
in  	in  	 IN	O
DMEM  	DMEM  	 NNP	B-NP
-0.1 	-0.1 	 NNP	O
%  	%  	 NN	O
bovine  	bovine  	 FW	B-NP
serum  	serum  	 FW	I-NP
albumin  	albumin  	 FW	I-NP
( 	( 	 -LRB-	O
BSA 	BSA 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
x-gal  	x-gal  	 JJ	B-NP
staining  	staining  	 NN	I-NP
for  	for  	 IN	I-NP
determination  	determination  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
fraction  	fraction  	 NN	I-NP
of  	of  	 IN	O
cells  	cells  	 NNS	O
infected  	infected  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
virus  	virus  	 NN	O
[  	[  	 -LRB-	O
31  	31  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
to  	to  	 TO	O
stimulation  	stimulation  	 VB	O
by  	by  	 IN	O
GnRH-A  	GnRH-A  	 JJ	B-NP
for  	for  	 IN	O
measurement  	measurement  	 NN	O
of  	of  	 IN	O
LH  	LH  	 NNP	B-NP
release 	release 	 NN	I-NP
.  	.  	 .	O
GnRH-stimulated  	GnRH-stimulated  	 NNP	B-NP
LH  	LH  	 NNP	I-NP
secretion  	secretion  	 VBD	O
Pituitary  	Pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
that  	that  	 WDT	O
had  	had  	 VBD	O
been  	been  	 VBN	O
re-trypsinized  	re-trypsinized  	 JJ	B-NP
72  	72  	 CD	O
h  	h  	 NN	O
after  	after  	 IN	O
infection  	infection  	 NN	B-NP
and  	and  	 CC	O
then  	then  	 RB	O
replated  	replated  	 JJ	O
( 	( 	 -LRB-	O
100,000  	100,000  	 CD	O
cells 	cells 	 NNS	B-NP
/ 	/ 	 VBP	I-NP
well  	well  	 RB	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
24-well  	24-well  	 JJ	O
poly-L-lysine  	poly-L-lysine  	 JJ	B-NP
coated  	coated  	 JJ	O
plate 	plate 	 NN	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
a  	a  	 DT	O
2  	2  	 CD	O
h  	h  	 CD	B-NP
preincubation  	preincubation  	 NNS	I-NP
were  	were  	 VBD	O
subsequently  	subsequently  	 RB	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
GnRH  	GnRH  	 JJ	B-NP
agonist  	agonist  	 NNS	I-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
10  	10  	 CD	O
-7M  	-7M  	 FW	O
D-Ala  	D-Ala  	 FW	O
6-  	6-  	 FW	O
des  	des  	 FW	O
Gly  	Gly  	 FW	O
10-  	10-  	 FW	O
GnRH  	GnRH  	 FW	O
ethylamide 	ethylamide 	 FW	O
;  	;  	 :	O
GnRH-A 	GnRH-A 	 NNP	B-NP
,  	,  	 ,	O
Sigma 	Sigma 	 NNP	B-NP
,  	,  	 ,	O
St.  	St.  	 NNP	B-NP
Louis 	Louis 	 NNP	O
,  	,  	 ,	O
MO 	MO 	 NNP	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
a  	a  	 DT	O
calcium  	calcium  	 JJ	B-NP
ionophore  	ionophore  	 NNS	I-NP
( 	( 	 -LRB-	O
A23187 	A23187 	 NNP	O
,  	,  	 ,	O
Sigma 	Sigma 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
3  	3  	 CD	O
h  	h  	 NNS	O
as  	as  	 RB	O
described  	described  	 VBN	O
by  	by  	 IN	O
Conn  	Conn  	 NNP	O
et  	et  	 FW	O
al.  	al.  	 FW	O
[  	[  	 -LRB-	O
34  	34  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
medium  	medium  	 NN	O
was  	was  	 VBD	O
removed  	removed  	 VBN	O
and  	and  	 CC	O
centrifuged  	centrifuged  	 NN	O
at  	at  	 IN	O
200  	200  	 CD	O
×  	×  	 CD	O
g  	g  	 NN	O
for  	for  	 IN	O
10  	10  	 CD	O
min  	min  	 NN	B-NP
to  	to  	 TO	O
pellet  	pellet  	 VB	O
any  	any  	 DT	O
detached  	detached  	 JJ	O
cells 	cells 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
supernatant  	supernatant  	 JJ	B-NP
solution  	solution  	 NN	I-NP
was  	was  	 VBD	O
either  	either  	 RB	O
used  	used  	 VBN	O
immediately  	immediately  	 RB	O
or  	or  	 CC	O
stored  	stored  	 VBD	O
at  	at  	 IN	O
-20°C  	-20°C  	 CD	O
prior  	prior  	 JJ	O
to  	to  	 TO	O
RIA 	RIA 	 NNP	B-NP
.  	.  	 .	O
LH  	LH  	 NNP	B-NP
RIAs  	RIAs  	 NNP	I-NP
were  	were  	 VBD	O
performed  	performed  	 VBN	O
using  	using  	 VBG	O
reagents  	reagents  	 NNS	O
and  	and  	 CC	O
instructions  	instructions  	 NNS	B-NP
provided  	provided  	 VBN	O
by  	by  	 IN	O
Dr.  	Dr.  	 NNP	B-NP
A.  	A.  	 NNP	O
F.  	F.  	 NNP	O
Parlow  	Parlow  	 NNP	O
on  	on  	 IN	O
behalf  	behalf  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
National  	National  	 NNP	B-NP
Hormone  	Hormone  	 NNP	I-NP
and  	and  	 CC	O
Pituitary  	Pituitary  	 NNP	O
Program 	Program 	 NNP	O
,  	,  	 ,	O
National  	National  	 NNP	O
Institute  	Institute  	 NNP	O
of  	of  	 IN	O
Diabetes  	Diabetes  	 NNP	O
and  	and  	 CC	O
Digestive  	Digestive  	 NNP	O
and  	and  	 CC	O
Kidney  	Kidney  	 NNP	O
Diseases 	Diseases 	 NNP	O
,  	,  	 ,	O
NIH 	NIH 	 NNP	B-NP
.  	.  	 .	O
Rat  	Rat  	 NNP	B-NP
LH  	LH  	 NNP	I-NP
( 	( 	 -LRB-	O
NIDDK-rLH-l-9 	NIDDK-rLH-l-9 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
radioiodinated 	radioiodinated 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
LH  	LH  	 NNP	B-NP
antiserum  	antiserum  	 NNS	I-NP
( 	( 	 -LRB-	O
NIDDK-anti-rLH-S-11 	NIDDK-anti-rLH-S-11 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
prepared  	prepared  	 VBN	O
in  	in  	 IN	O
rabbits 	rabbits 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
reference  	reference  	 NN	B-NP
standard  	standard  	 NN	I-NP
was  	was  	 VBD	O
NIDDK-rLH-RP3 	NIDDK-rLH-RP3 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
mean  	mean  	 JJ	B-NP
EC  	EC  	 NNP	I-NP
50  	50  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
standard  	standard  	 JJ	O
curves  	curves  	 NNS	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
10 	10 	 CD	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
0.59  	0.59  	 CD	O
ng  	ng  	 NN	B-NP
with  	with  	 IN	O
a  	a  	 DT	O
coefficient  	coefficient  	 NN	O
of  	of  	 IN	O
variation  	variation  	 NN	O
of  	of  	 IN	O
4.4 	4.4 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
GNRH-stimulated  	GNRH-stimulated  	 NNP	O
3H-inositol  	3H-inositol  	 NNP	O
phosphate  	phosphate  	 JJ	B-NP
accumulation  	accumulation  	 NN	I-NP
in  	in  	 IN	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
Total  	Total  	 JJ	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
]  	]  	 -RRB-	O
inositol  	inositol  	 JJ	B-NP
phosphate  	phosphate  	 JJ	I-NP
accumulation  	accumulation  	 NN	I-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
in  	in  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
]  	]  	 -RRB-	O
myoinositol-labeled  	myoinositol-labeled  	 JJ	B-NP
pituitary  	pituitary  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
as  	as  	 RB	O
described  	described  	 VBN	O
earlier  	earlier  	 RBR	O
[  	[  	 -LRB-	O
22  	22  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
At  	At  	 IN	O
48  	48  	 CD	O
h  	h  	 NN	O
after  	after  	 IN	O
infection  	infection  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
pituitary  	pituitary  	 JJ	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
incubation  	incubation  	 JJ	B-NP
medium  	medium  	 NN	I-NP
was  	was  	 VBD	O
removed  	removed  	 VBN	O
and  	and  	 CC	O
replaced  	replaced  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
balanced  	balanced  	 JJ	O
salt  	salt  	 NN	B-NP
solution  	solution  	 NN	I-NP
( 	( 	 -LRB-	O
10  	10  	 CD	O
mM  	mM  	 JJ	B-NP
Hepes 	Hepes 	 NNP	I-NP
,  	,  	 ,	O
pH7.4 	pH7.4 	 NNP	B-NP
,  	,  	 ,	O
135  	135  	 CD	O
mM  	mM  	 JJ	B-NP
NaCI 	NaCI 	 NN	I-NP
,  	,  	 ,	O
4.5  	4.5  	 CD	O
mM  	mM  	 JJ	B-NP
KCL 	KCL 	 NNP	I-NP
,  	,  	 ,	O
1.5  	1.5  	 CD	O
mM  	mM  	 JJ	O
CaCl  	CaCl  	 JJ	B-NP
2  	2  	 CD	O
,  	,  	 ,	O
0.5  	0.5  	 CD	O
mM  	mM  	 JJ	O
MgCL  	MgCL  	 JJ	O
2  	2  	 CD	O
,  	,  	 ,	O
1.0  	1.0  	 CD	O
mM  	mM  	 JJ	O
NaH  	NaH  	 JJ	B-NP
2  	2  	 CD	O
PO4 	PO4 	 CD	B-NP
,  	,  	 ,	O
5.6  	5.6  	 CD	O
mM  	mM  	 JJ	B-NP
glucose 	glucose 	 NN	I-NP
,  	,  	 ,	O
0.3 	0.3 	 CD	O
%  	%  	 NN	O
BSA 	BSA 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
10  	10  	 CD	O
-9M  	-9M  	 CD	O
estradiol 	estradiol 	 CD	O
)  	)  	 -RRB-	O
containing  	containing  	 VBG	O
5  	5  	 CD	O
μCi  	μCi  	 NN	B-NP
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-myoinositol 	-myoinositol 	 JJ	O
/ 	/ 	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
medium 	medium 	 NN	O
.  	.  	 .	O
After  	After  	 IN	O
a  	a  	 DT	O
further  	further  	 JJ	O
24  	24  	 CD	O
h 	h 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
recovered  	recovered  	 VBN	O
by  	by  	 IN	O
trypinization 	trypinization 	 NN	B-NP
,  	,  	 ,	O
counted 	counted 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
replated  	replated  	 NN	O
in  	in  	 IN	O
balanced  	balanced  	 JJ	O
salt  	salt  	 NN	B-NP
solution  	solution  	 NN	I-NP
( 	( 	 -LRB-	O
400,000  	400,000  	 CD	O
-  	-  	 :	O
500,000  	500,000  	 CD	O
cells 	cells 	 NNS	B-NP
/ 	/ 	 VBP	I-NP
well  	well  	 RB	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
24-well  	24-well  	 JJ	O
plate 	plate 	 NN	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
a  	a  	 DT	O
2  	2  	 CD	O
h  	h  	 CD	B-NP
preincubation 	preincubation 	 NNS	I-NP
.  	.  	 .	O
Then 	Then 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
stimulated  	stimulated  	 VBN	O
with  	with  	 IN	O
GnRH-A  	GnRH-A  	 NNP	B-NP
( 	( 	 -LRB-	O
10  	10  	 CD	O
-7M  	-7M  	 CD	O
for  	for  	 IN	O
one  	one  	 CD	O
hr 	hr 	 CD	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
5  	5  	 CD	O
mM  	mM  	 JJ	B-NP
LiCI.  	LiCI.  	 NNP	I-NP
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
-inositol  	-inositol  	 JJ	O
phosphate  	phosphate  	 JJ	B-NP
accumulation  	accumulation  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
was  	was  	 VBD	O
then  	then  	 RB	O
measured  	measured  	 VBN	O
using  	using  	 VBG	O
ion  	ion  	 JJ	B-NP
exchange  	exchange  	 NN	I-NP
chromatography  	chromatography  	 VBZ	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
liquid  	liquid  	 JJ	B-NP
scintillation  	scintillation  	 JJ	I-NP
spectroscopy  	spectroscopy  	 NNS	I-NP
[  	[  	 -LRB-	O
22  	22  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Immunoblots  	Immunoblots  	 NNP	B-NP
for  	for  	 IN	I-NP
RGS3  	RGS3  	 CD	I-NP
An  	An  	 DT	O
antibody  	antibody  	 NN	B-NP
to  	to  	 TO	O
hexa-histidine-tagged  	hexa-histidine-tagged  	 JJ	B-NP
human  	human  	 JJ	O
RGS3T  	RGS3T  	 NN	O
was  	was  	 VBD	O
prepared  	prepared  	 VBN	O
in  	in  	 IN	O
chickens 	chickens 	 NNS	O
.  	.  	 .	O
RGS3T  	RGS3T  	 NNP	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
is  	is  	 VBZ	O
the  	the  	 DT	O
carboxy  	carboxy  	 JJ	B-NP
terminal  	terminal  	 NN	I-NP
206  	206  	 CD	O
amino  	amino  	 CD	B-NP
acids  	acids  	 NNS	I-NP
( 	( 	 -LRB-	O
a.a.  	a.a.  	 NNP	O
314-519 	314-519 	 NNP	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
RGS3  	RGS3  	 NNP	B-NP
and  	and  	 CC	O
is  	is  	 VBZ	O
represented  	represented  	 VBN	O
by  	by  	 IN	O
nt  	nt  	 JJ	O
1227-1847  	1227-1847  	 NN	O
of  	of  	 IN	O
RGS3  	RGS3  	 NNP	B-NP
cDNA  	cDNA  	 NNP	I-NP
( 	( 	 -LRB-	O
Genbank  	Genbank  	 UH	B-NP
Accession  	Accession  	 UH	I-NP
# 	# 	 #	O
U27655 	U27655 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
To  	To  	 TO	O
prepare  	prepare  	 VB	O
hexa-histidine  	hexa-histidine  	 JJ	B-NP
amino  	amino  	 JJ	O
terminally-tagged  	terminally-tagged  	 JJ	O
RGS3T 	RGS3T 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
modified  	modified  	 VBD	O
RGS3T  	RGS3T  	 NNP	O
cDNA  	cDNA  	 NNP	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
using  	using  	 VBG	O
PCR  	PCR  	 NNP	B-NP
with  	with  	 IN	O
primers  	primers  	 NNS	O
containing  	containing  	 VBG	B-NP
restriction  	restriction  	 NN	I-NP
sites  	sites  	 NNS	I-NP
( 	( 	 -LRB-	O
the  	the  	 DT	O
5 	5 	 CD	O
'  	'  	 POS	O
primer  	primer  	 NN	O
incorporated  	incorporated  	 VBN	O
a  	a  	 DT	O
Bam  	Bam  	 NNP	B-NP
HI  	HI  	 NNP	I-NP
site 	site 	 NN	I-NP
,  	,  	 ,	O
whereas  	whereas  	 IN	O
the  	the  	 DT	O
3 	3 	 CD	O
'  	'  	 POS	O
primer  	primer  	 NN	O
bore  	bore  	 VBD	O
an  	an  	 DT	O
Nde  	Nde  	 NNP	B-NP
1  	1  	 CD	O
site 	site 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
PCR  	PCR  	 NNP	B-NP
product  	product  	 NN	I-NP
was  	was  	 VBD	O
then  	then  	 RB	O
cloned  	cloned  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
pET15b  	pET15b  	 JJ	O
vector  	vector  	 NN	O
which  	which  	 WDT	O
carries  	carries  	 VBZ	O
an  	an  	 DT	O
N-terminal  	N-terminal  	 JJ	B-NP
Histag  	Histag  	 NNP	I-NP
sequence  	sequence  	 VBD	I-NP
followed  	followed  	 VBN	O
by  	by  	 IN	O
BamH1  	BamH1  	 NNP	B-NP
and  	and  	 CC	O
Nde  	Nde  	 NNP	B-NP
1  	1  	 CD	O
cloning  	cloning  	 CD	B-NP
sites  	sites  	 NNS	I-NP
( 	( 	 -LRB-	O
Novagen  	Novagen  	 NNP	B-NP
Inc. 	Inc. 	 NNP	O
,  	,  	 ,	O
Madison 	Madison 	 NNP	O
,  	,  	 ,	O
WI 	WI 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
resulting  	resulting  	 VBG	O
plasmid  	plasmid  	 JJ	B-NP
DNA  	DNA  	 NN	I-NP
was  	was  	 VBD	O
nucleotide-sequenced  	nucleotide-sequenced  	 JJ	B-NP
to  	to  	 TO	O
confirm  	confirm  	 VB	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
RGS3T  	RGS3T  	 NNP	O
cDNA 	cDNA 	 NNP	O
.  	.  	 .	O
The  	The  	 DT	O
cDNA  	cDNA  	 NN	B-NP
was  	was  	 VBD	O
then  	then  	 RB	O
used  	used  	 VBN	O
to  	to  	 TO	O
transform  	transform  	 VB	O
E.  	E.  	 NNP	B-NP
coli  	coli  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
BL21 	BL21 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
DE3 	DE3 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
strain 	strain 	 NN	I-NP
.  	.  	 .	O
Protein  	Protein  	 NN	B-NP
induction  	induction  	 NNS	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
using  	using  	 VBG	O
isopropyl-β-D-thiogalactopyranoside  	isopropyl-β-D-thiogalactopyranoside  	 JJ	B-NP
( 	( 	 -LRB-	O
IPTG 	IPTG 	 NNP	O
)  	)  	 -RRB-	O
as  	as  	 RB	O
described  	described  	 VBN	O
by  	by  	 IN	O
Novagen  	Novagen  	 NNP	B-NP
Inc 	Inc 	 NNP	O
.  	.  	 .	O
Inclusion  	Inclusion  	 JJ	B-NP
bodies  	bodies  	 NNS	I-NP
containing  	containing  	 VBG	O
the  	the  	 DT	O
protein  	protein  	 NN	B-NP
were  	were  	 VBD	O
prepared  	prepared  	 VBN	O
and  	and  	 CC	O
then  	then  	 RB	O
solubized  	solubized  	 VBN	O
in  	in  	 IN	O
6  	6  	 CD	O
M  	M  	 NNP	O
guanidine 	guanidine 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
Histag  	Histag  	 NNP	O
RGS3T  	RGS3T  	 NNP	O
protein  	protein  	 NN	O
was  	was  	 VBD	O
purified  	purified  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
Ni  	Ni  	 NNP	O
2+resin  	2+resin  	 NNP	O
using  	using  	 VBG	O
a  	a  	 DT	O
Pharmacia  	Pharmacia  	 NNP	B-NP
Hi-Trap  	Hi-Trap  	 NNP	I-NP
1  	1  	 CD	O
ml  	ml  	 JJ	B-NP
Chelating  	Chelating  	 NNP	I-NP
Column  	Column  	 NNP	I-NP
( 	( 	 -LRB-	O
Pharmacia  	Pharmacia  	 NNP	B-NP
Biotech 	Biotech 	 NNP	I-NP
,  	,  	 ,	O
Piscataway 	Piscataway 	 NNP	B-NP
,  	,  	 ,	O
NJ 	NJ 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Antibodies  	Antibodies  	 NNS	B-NP
to  	to  	 TO	O
Histag  	Histag  	 NNP	O
RGS3T  	RGS3T  	 NNP	O
protein  	protein  	 NN	O
were  	were  	 VBD	O
prepared  	prepared  	 VBN	O
in  	in  	 IN	O
chickens  	chickens  	 NNS	O
( 	( 	 -LRB-	O
Aves  	Aves  	 NNP	B-NP
Labs 	Labs 	 NNPS	O
,  	,  	 ,	O
Inc. 	Inc. 	 NNP	O
,  	,  	 ,	O
Tigard 	Tigard 	 NNP	B-NP
,  	,  	 ,	O
OR 	OR 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
chicken  	chicken  	 NN	O
was  	was  	 VBD	O
injected  	injected  	 VBN	O
with  	with  	 IN	O
145  	145  	 CD	O
μg  	μg  	 NN	B-NP
of  	of  	 IN	O
RGS3T  	RGS3T  	 CD	O
into  	into  	 IN	O
the  	the  	 DT	O
breast  	breast  	 NN	O
muscle  	muscle  	 NN	O
on  	on  	 IN	O
four  	four  	 CD	O
separate  	separate  	 JJ	O
occasions 	occasions 	 NNS	O
;  	;  	 :	O
the  	the  	 DT	O
first  	first  	 JJ	O
injection  	injection  	 NN	B-NP
was  	was  	 VBD	O
in  	in  	 IN	O
complete  	complete  	 JJ	O
Freund 	Freund 	 NNP	O
's  	's  	 POS	O
adjuvant 	adjuvant 	 NN	B-NP
,  	,  	 ,	O
whereas  	whereas  	 IN	O
injections  	injections  	 JJ	O
2-4  	2-4  	 NN	O
were  	were  	 VBD	O
made  	made  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
1 	1 	 CD	O
: 	: 	 :	O
1  	1  	 CD	O
dilution  	dilution  	 NN	O
of  	of  	 IN	O
complete  	complete  	 JJ	O
and  	and  	 CC	O
incomplete  	incomplete  	 JJ	O
Freund 	Freund 	 NNP	O
's  	's  	 POS	O
adjuvant 	adjuvant 	 NN	B-NP
.  	.  	 .	O
One  	One  	 CD	O
week  	week  	 NN	B-NP
after  	after  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
injection 	injection 	 NN	B-NP
,  	,  	 ,	O
6  	6  	 CD	O
immune  	immune  	 JJ	B-NP
eggs  	eggs  	 NNS	I-NP
were  	were  	 VBD	O
collected 	collected 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
IgY  	IgY  	 JJ	B-NP
fraction  	fraction  	 NN	I-NP
purified  	purified  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
6  	6  	 CD	O
eggs  	eggs  	 NNS	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 RB	O
from  	from  	 IN	O
3  	3  	 CD	O
pre-immune  	pre-immune  	 JJ	B-NP
eggs  	eggs  	 NNS	I-NP
collected  	collected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
hen 	hen 	 NN	O
.  	.  	 .	O
Immunoblots  	Immunoblots  	 NNP	B-NP
for  	for  	 IN	I-NP
RGS3  	RGS3  	 CD	I-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
performed  	performed  	 VBN	O
as  	as  	 RB	O
described  	described  	 VBN	O
previously  	previously  	 RB	O
by  	by  	 IN	O
us  	us  	 PRP	O
[  	[  	 -LRB-	O
22  	22  	 CD	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
brief 	brief 	 JJ	O
,  	,  	 ,	O
rat  	rat  	 JJ	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
at  	at  	 IN	O
72  	72  	 CD	O
h  	h  	 NN	O
after  	after  	 IN	O
adeno-RGS3  	adeno-RGS3  	 CD	B-NP
infection  	infection  	 NN	I-NP
( 	( 	 -LRB-	O
5  	5  	 CD	O
M.O.I. 	M.O.I. 	 CD	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
by  	by  	 IN	O
trypsinization 	trypsinization 	 NN	B-NP
,  	,  	 ,	O
homogenized 	homogenized 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
protein  	protein  	 NN	B-NP
determination  	determination  	 NN	I-NP
made 	made 	 VBD	O
.  	.  	 .	O
Fifty  	Fifty  	 JJ	O
μg  	μg  	 JJ	B-NP
protein  	protein  	 NN	I-NP
samples  	samples  	 NNS	I-NP
were  	were  	 VBD	O
heated  	heated  	 VBN	O
in  	in  	 IN	O
SDS-PAGE  	SDS-PAGE  	 JJ	B-NP
sample  	sample  	 NN	I-NP
buffer  	buffer  	 NN	I-NP
containing  	containing  	 VBG	I-NP
β-mercaptoethanol  	β-mercaptoethanol  	 JJ	I-NP
and  	and  	 CC	O
then  	then  	 RB	O
electrophoresed  	electrophoresed  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
10 	10 	 CD	O
%  	%  	 NN	O
SDS-polyacrylamide  	SDS-polyacrylamide  	 JJ	B-NP
gel 	gel 	 NN	I-NP
.  	.  	 .	O
Separated  	Separated  	 JJ	O
proteins  	proteins  	 NNS	O
were  	were  	 VBD	O
electroblotted  	electroblotted  	 VBN	O
onto  	onto  	 IN	O
nylon  	nylon  	 JJ	B-NP
membranes  	membranes  	 NNS	I-NP
( 	( 	 -LRB-	O
Millipore  	Millipore  	 NNP	B-NP
Corp. 	Corp. 	 NNP	O
,  	,  	 ,	O
Bedford 	Bedford 	 NNP	O
,  	,  	 ,	O
MA 	MA 	 NNP	O
)  	)  	 -RRB-	O
which  	which  	 WDT	O
were  	were  	 VBD	O
then  	then  	 RB	O
incubated  	incubated  	 VBN	O
for  	for  	 IN	O
2  	2  	 CD	O
h  	h  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
blocking  	blocking  	 JJ	O
solution  	solution  	 NN	B-NP
containing  	containing  	 VBG	O
5 	5 	 CD	O
%  	%  	 NN	O
non-fat  	non-fat  	 JJ	B-NP
dry  	dry  	 JJ	O
milk  	milk  	 NN	O
in  	in  	 IN	O
phosphate  	phosphate  	 JJ	O
buffered  	buffered  	 NNS	O
saline  	saline  	 VBP	O
containing  	containing  	 VBG	O
0.02 	0.02 	 CD	O
%  	%  	 NN	O
Tween-20 	Tween-20 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
primary  	primary  	 JJ	B-NP
antibody  	antibody  	 NN	I-NP
( 	( 	 -LRB-	O
chicken  	chicken  	 NN	B-NP
IgY 	IgY 	 NN	I-NP
,  	,  	 ,	O
62.5  	62.5  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml 	ml 	 CD	I-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
diluted  	diluted  	 VBN	O
in  	in  	 IN	O
blocking  	blocking  	 VBG	B-NP
solution  	solution  	 NN	I-NP
and  	and  	 CC	O
incubated  	incubated  	 JJ	O
overnight  	overnight  	 JJ	O
at  	at  	 IN	O
4°C  	4°C  	 CD	O
with  	with  	 IN	O
the  	the  	 DT	O
nylon  	nylon  	 JJ	B-NP
membrane 	membrane 	 NN	I-NP
.  	.  	 .	O
Blots  	Blots  	 NNP	O
were  	were  	 VBD	O
then  	then  	 RB	O
incubated  	incubated  	 VBN	O
for  	for  	 IN	O
2  	2  	 CD	O
h  	h  	 NN	O
at  	at  	 IN	O
room  	room  	 NN	B-NP
temperature  	temperature  	 NN	I-NP
in  	in  	 IN	O
alkaline  	alkaline  	 FW	B-NP
phosphatase-conjugated  	phosphatase-conjugated  	 FW	I-NP
goat  	goat  	 FW	I-NP
anti-chicken  	anti-chicken  	 FW	I-NP
IgY  	IgY  	 FW	I-NP
( 	( 	 -LRB-	O
0.1  	0.1  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml  	ml  	 NNS	I-NP
diluted  	diluted  	 VBN	O
in  	in  	 IN	O
blocking  	blocking  	 VBG	B-NP
solution 	solution 	 NN	I-NP
;  	;  	 :	O
Aves  	Aves  	 NNP	B-NP
Labs 	Labs 	 NNPS	O
,  	,  	 ,	O
Tigard 	Tigard 	 NNP	B-NP
,  	,  	 ,	O
OR 	OR 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Color  	Color  	 NN	B-NP
development  	development  	 NN	I-NP
was  	was  	 VBD	O
achieved  	achieved  	 VBN	O
by  	by  	 IN	O
incubating  	incubating  	 VBG	O
the  	the  	 DT	O
membrane  	membrane  	 NN	O
in  	in  	 IN	O
substrate  	substrate  	 NNS	O
[ 	[ 	 -LRB-	O
( 	( 	 -LRB-	O
5-bromo-4-chloro-3-indolyl  	5-bromo-4-chloro-3-indolyl  	 FW	O
phosphate-nitrobluetetra-zolium  	phosphate-nitrobluetetra-zolium  	 FW	O
chloride 	chloride 	 FW	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
BCIP-NBT 	BCIP-NBT 	 NNP	B-NP
) 	) 	 -RRB-	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Assay  	Assay  	 NNP	B-NP
of  	of  	 IN	I-NP
LH  	LH  	 NNP	I-NP
contents  	contents  	 NNS	I-NP
in  	in  	 IN	O
pituitary  	pituitary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
For  	For  	 IN	I-NP
LH  	LH  	 NNP	I-NP
RIA  	RIA  	 NNP	I-NP
measurements  	measurements  	 NNS	I-NP
of  	of  	 IN	O
cell  	cell  	 NN	O
contents 	contents 	 NNS	O
,  	,  	 ,	O
1  	1  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
5anterior  	5anterior  	 CD	O
pituitary  	pituitary  	 CD	O
cells  	cells  	 NNS	O
infected 	infected 	 VBN	O
,  	,  	 ,	O
or  	or  	 CC	O
not 	not 	 RB	O
,  	,  	 ,	O
72  	72  	 CD	O
h  	h  	 NNS	O
previously  	previously  	 RB	O
with  	with  	 IN	O
adeno-RGS3  	adeno-RGS3  	 NNP	B-NP
or  	or  	 CC	O
adeno-βgal  	adeno-βgal  	 NNP	B-NP
were  	were  	 VBD	O
trypsinized  	trypsinized  	 JJ	O
and  	and  	 CC	O
plated  	plated  	 NN	O
for  	for  	 IN	O
2  	2  	 CD	O
h 	h 	 NNS	B-NP
.  	.  	 .	I-NP
LH  	LH  	 NNP	I-NP
was  	was  	 VBD	O
extracted  	extracted  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
[  	[  	 -LRB-	O
36  	36  	 CD	O
]  	]  	 -RRB-	O
by  	by  	 IN	O
removing  	removing  	 VBG	O
and  	and  	 CC	O
discarding  	discarding  	 VBG	O
the  	the  	 DT	O
medium  	medium  	 NN	O
and  	and  	 CC	O
adding  	adding  	 VBG	O
1  	1  	 CD	O
ml  	ml  	 CD	O
extraction  	extraction  	 JJ	B-NP
buffer  	buffer  	 NN	I-NP
( 	( 	 -LRB-	O
150  	150  	 CD	O
mM  	mM  	 JJ	B-NP
NaCI 	NaCI 	 NN	I-NP
,  	,  	 ,	O
50  	50  	 CD	O
mM  	mM  	 JJ	B-NP
Tris 	Tris 	 NNP	I-NP
,  	,  	 ,	O
5  	5  	 CD	O
mM  	mM  	 JJ	B-NP
EDTA 	EDTA 	 NNP	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
bacitracin 	bacitracin 	 NN	I-NP
,  	,  	 ,	O
pH  	pH  	 JJ	O
7.4 	7.4 	 CD	O
)  	)  	 -RRB-	O
followed  	followed  	 VBD	O
by  	by  	 IN	O
freeze-thawing  	freeze-thawing  	 JJ	O
twice 	twice 	 RB	O
.  	.  	 .	O
After  	After  	 IN	O
centrifugation 	centrifugation 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
supernatant  	supernatant  	 NN	B-NP
was  	was  	 VBD	O
removed  	removed  	 VBN	O
and  	and  	 CC	O
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
LH  	LH  	 NNP	B-NP
RIA  	RIA  	 NNP	I-NP
as  	as  	 RB	O
described  	described  	 VBN	O
above 	above 	 IN	O
.  	.  	 .	O
Measurements  	Measurements  	 NNS	B-NP
of  	of  	 IN	I-NP
GnRH  	GnRH  	 JJ	I-NP
receptors  	receptors  	 NNS	I-NP
by  	by  	 IN	O
receptor  	receptor  	 NN	B-NP
radioassay  	radioassay  	 NNS	I-NP
( 	( 	 -LRB-	O
RRA 	RRA 	 NNP	B-NP
)  	)  	 -RRB-	O
About  	About  	 IN	O
3  	3  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
6pituitary  	6pituitary  	 CD	O
cells  	cells  	 NNS	O
infected 	infected 	 VBN	O
,  	,  	 ,	O
or  	or  	 CC	O
not 	not 	 RB	O
,  	,  	 ,	O
72  	72  	 CD	O
h  	h  	 NNS	O
previously  	previously  	 RB	O
with  	with  	 IN	O
adeno-βgal  	adeno-βgal  	 JJ	B-NP
or  	or  	 CC	O
adeno-RGS3  	adeno-RGS3  	 NNP	B-NP
were  	were  	 VBD	O
trypsinized 	trypsinized 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
cell  	cell  	 NN	O
membranes  	membranes  	 VBZ	O
containing  	containing  	 VBG	O
the  	the  	 DT	O
GnRH  	GnRH  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
were  	were  	 VBD	O
prepared  	prepared  	 VBN	O
by  	by  	 IN	O
placing  	placing  	 VBG	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
in  	in  	 IN	O
a  	a  	 DT	O
Dounce  	Dounce  	 JJ	B-NP
homogenizer  	homogenizer  	 NNS	I-NP
( 	( 	 -LRB-	O
Kontes  	Kontes  	 NNP	B-NP
Co. 	Co. 	 NNP	O
,  	,  	 ,	O
Vineland 	Vineland 	 NNP	B-NP
,  	,  	 ,	O
NJ 	NJ 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
disrupting  	disrupting  	 VBG	O
them  	them  	 PRP	O
with  	with  	 IN	O
30  	30  	 CD	O
strokes  	strokes  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
pestle 	pestle 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
cell  	cell  	 NN	O
membranes  	membranes  	 NNS	O
were  	were  	 VBD	O
pelleted  	pelleted  	 VBN	O
by  	by  	 IN	O
centrifugation  	centrifugation  	 NN	B-NP
at  	at  	 IN	O
26,000  	26,000  	 CD	O
×  	×  	 CD	O
g  	g  	 NNS	O
and  	and  	 CC	O
then  	then  	 RB	O
resuspended  	resuspended  	 VBN	O
in  	in  	 IN	O
10  	10  	 CD	O
mM  	mM  	 JJ	O
Tris  	Tris  	 JJ	B-NP
buffer 	buffer 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
GnRH  	GnRH  	 JJ	B-NP
RRA  	RRA  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
membranes  	membranes  	 NN	O
was  	was  	 VBD	O
performed  	performed  	 VBN	O
as  	as  	 RB	O
described  	described  	 VBN	O
previously  	previously  	 RB	O
[  	[  	 -LRB-	O
22  	22  	 CD	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Cell  	Cell  	 NN	O
membranes  	membranes  	 NNS	O
and  	and  	 CC	O
1  	1  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
5cpm  	5cpm  	 CD	O
[  	[  	 -LRB-	O
125I 	125I 	 NNP	O
] 	] 	 -RRB-	O
GnRH-A  	GnRH-A  	 NNP	B-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
0°C  	0°C  	 CD	O
for  	for  	 IN	O
90  	90  	 CD	O
min 	min 	 NNS	B-NP
.  	.  	 .	O
Nonspecific  	Nonspecific  	 JJ	B-NP
binding  	binding  	 NN	I-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
as  	as  	 IN	O
counts  	counts  	 NNS	O
per  	per  	 IN	O
min  	min  	 VBG	B-NP
bound  	bound  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
10  	10  	 CD	O
-6M  	-6M  	 CD	O
unlabeled  	unlabeled  	 JJ	O
GnRH-A 	GnRH-A 	 NN	B-NP
.  	.  	 .	O
Bound  	Bound  	 NNP	O
and  	and  	 CC	O
free  	free  	 JJ	O
[  	[  	 -LRB-	O
125I 	125I 	 NNP	O
] 	] 	 -RRB-	O
GnRH-A  	GnRH-A  	 NNP	B-NP
were  	were  	 VBD	O
separated  	separated  	 VBN	O
by  	by  	 IN	O
filtration 	filtration 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
filters  	filters  	 NNS	O
were  	were  	 VBD	O
counted  	counted  	 VBN	O
by  	by  	 IN	O
γ-scintillation  	γ-scintillation  	 JJ	B-NP
spectrometry 	spectrometry 	 NN	I-NP
.  	.  	 .	O
Data  	Data  	 NNP	O
analysis  	analysis  	 NN	O
The  	The  	 DT	O
results  	results  	 NNS	O
are  	are  	 VBP	O
presented  	presented  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
mean  	mean  	 JJ	B-NP
±  	±  	 NNP	O
SEM  	SEM  	 NNP	B-NP
of  	of  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
three  	three  	 CD	O
independent  	independent  	 JJ	O
experiments  	experiments  	 NNS	O
unless  	unless  	 IN	O
indicated  	indicated  	 VBN	O
otherwise 	otherwise 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
statistical  	statistical  	 JJ	B-NP
tests  	tests  	 NNS	I-NP
were  	were  	 VBD	O
one-way  	one-way  	 JJ	B-NP
or  	or  	 CC	O
two-way  	two-way  	 JJ	O
analyses  	analyses  	 NNS	O
of  	of  	 IN	O
variance  	variance  	 NN	O
with  	with  	 IN	O
significant  	significant  	 JJ	O
differences  	differences  	 NNS	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Student  	Student  	 NN	O
-  	-  	 :	O
Newman-Keuls  	Newman-Keuls  	 JJ	B-NP
method 	method 	 NN	O
.  	.  	 .	O
Statistical  	Statistical  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
using  	using  	 VBG	O
Sigma  	Sigma  	 NNP	B-NP
Stat  	Stat  	 NNP	I-NP
Statistical  	Statistical  	 NNP	I-NP
Software  	Software  	 NNP	I-NP
for  	for  	 IN	O
Windows  	Windows  	 NNP	O
( 	( 	 -LRB-	O
Jandel  	Jandel  	 NNP	B-NP
Scientific 	Scientific 	 NNP	I-NP
,  	,  	 ,	O
San  	San  	 NNP	O
Rafael 	Rafael 	 NNP	O
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
